<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Immunol Res</journal-id><journal-id journal-id-type="iso-abbrev">J Immunol Res</journal-id><journal-id journal-id-type="publisher-id">JIR</journal-id><journal-title-group><journal-title>Journal of Immunology Research</journal-title></journal-title-group><issn pub-type="ppub">2314-8861</issn><issn pub-type="epub">2314-7156</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6757286</article-id><article-id pub-id-type="doi">10.1155/2019/8028725</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>The Role of Innate Leukocytes during Influenza Virus Infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lamichhane</surname><given-names>Prem P.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3104-2823</contrib-id><name><surname>Samarasinghe</surname><given-names>Amali E.</given-names></name><email>asamaras@uthsc.edu</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38103, USA</aff><aff id="I2">
<sup>2</sup>Children's Foundation Research Institute, Memphis, TN 38103, USA</aff><author-notes><fn fn-type="other"><p>Guest Editor: Patricio L. Acosta</p></fn></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>12</day><month>9</month><year>2019</year></pub-date><volume>2019</volume><elocation-id>8028725</elocation-id><history><date date-type="received"><day>9</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>15</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Prem P. Lamichhane and Amali E. Samarasinghe.</copyright-statement><copyright-year>2019</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Influenza virus infection is a serious threat to humans and animals, with the potential to cause severe pneumonia and death. Annual vaccination strategies are a mainstay to prevent complications related to influenza. However, protection from the emerging subtypes of influenza A viruses (IAV) even in vaccinated individuals is challenging. Innate immune cells are the first cells to respond to IAV infection in the respiratory tract. Virus replication-induced production of cytokines from airway epithelium recruits innate immune cells to the site of infection. These leukocytes, namely, neutrophils, monocytes, macrophages, dendritic cells, eosinophils, natural killer cells, innate lymphoid cells, and <italic>&#x003b3;&#x003b4;</italic> T cells, become activated in response to IAV, to contain the virus and protect the airway epithelium while triggering the adaptive arm of the immune system. This review addresses different anti-influenza virus schemes of innate immune cells and how these cells fine-tune the balance between immunoprotection and immunopathology during IAV infection. Detailed understanding on how these innate responders execute anti-influenza activity will help to identify novel therapeutic targets to halt IAV replication and associated immunopathology.</p></abstract><funding-group><award-group><funding-source>National Institutes of Health</funding-source><award-id>R01-AI125481</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Respiratory viruses infect millions around the world each year causing a range of symptoms and claiming thousands of lives [<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B3" ref-type="bibr">3</xref>]. Some viruses such as respiratory syncytial virus are lethal to the very young but harmless to most adults [<xref rid="B4" ref-type="bibr">4</xref>]. Other viruses, such as rhinovirus, cause essentially the same symptoms (predominantly a runny nose) in any age group [<xref rid="B5" ref-type="bibr">5</xref>]. Still others like influenza A virus (IAV) can cause severe infections in patients across age groups during one season, mild symptoms in another year or be lethal in yet another season [<xref rid="B6" ref-type="bibr">6</xref>]. In fact, IAV infections cause seasonal epidemics and global pandemics and are a major cause for public health concern. Although generally milder than pandemics, seasonal influenza epidemics can cause around 650,000 deaths globally each year [<xref rid="B7" ref-type="bibr">7</xref>]. Despite mainstay vaccination strategies to minimize IAV infections, influenza pandemics have occurred once every 10-30 years, primarily due to cross-species transmission and antigenic shifts in the virus [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>].</p><p>As a member of the Orthomyxoviridae family, IAV is an enveloped virus with an octasegmented negative sense, single-stranded RNA genome [<xref rid="B6" ref-type="bibr">6</xref>]. At present, 18 hemagglutinin (HA) and 11 neuraminidase (NA) subtypes of IAV are documented to circulate in nature [<xref rid="B10" ref-type="bibr">10</xref>]. Only two HA subtypes of IAV (H1N1 and H3N2) and two lineages of influenza B viruses (Victoria and Yamagata) cause annual epidemics in humans [<xref rid="B6" ref-type="bibr">6</xref>]. However, IAVs dominate, inducing more severe morbidity and mortality compared to influenza B viruses, therefore, will be the focus of this review [<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>].</p><p>Rapid changes in IAV surface antigens through antigenic shift have resulted in three pandemics during the 20<sup>th</sup> century [<xref rid="B14" ref-type="bibr">14</xref>]. Avian IAV subtypes (H5N1, H7N1, H7N2, H7N3, H7N9, H9N2, and H10N8) can cross the species barrier to infect humans [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>] and cause severe, lethal disease. In fact, H5N1 highly pathogenic avian influenza (HPAI) and the H7N9 low pathogenic avian influenza viruses pose a serious public health concern due to their respective high fatality rates of 52.79% and 39.42% [<xref rid="B17" ref-type="bibr">17</xref>]. The most severe H1N1 influenza pandemic occurred in 1918 claiming over 50 million lives [<xref rid="B18" ref-type="bibr">18</xref>] while the last H1N1 pandemic in 2009 (pH1N1) is estimated to have claimed ~200,000 lives across the globe [<xref rid="B19" ref-type="bibr">19</xref>]. While annual vaccinations are highly encouraged by public health agencies, poor adherence and low efficacy increase the need for better strategies to understand host responses during IAV pathogenesis in order to delineate other mechanisms which enhance antiviral immunity.</p><p>Primary and secondary immune barriers play a crucial role in safeguarding the host against influenza. Physical barriers of the immune system including soluble components like mucus, collectins, and antimicrobial peptides provide the first line of defense by mitigating virus exposure to underlying airway epithelial cells which are the principal site for IAV replication [<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>]. Upon breaching these physical barriers, IAVs bind to sialic acid receptors on airway epithelial cells and enter these cells to complete replicative cycles within, destroying infected cells in the process [<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>]. Predilections for specific sialic acid linkages may restrict IAV to the upper respiratory tract. However, alterations in the sialic acid linkage preferences, particularly in reassortant viruses, can render IAV more adept at lower respiratory tract infection and dissemination [<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>]. Infection of the epithelium activates the innate branch of the immune system which consists of humoral/soluble as well as cellular components.</p><p>Infected airway epithelial cells trigger innate immune responses in two ways. First, viral RNAs within infected cells are sensed by pattern recognition receptors such as toll-like receptors, nucleotide-binding oligomerization domain-like receptors, or retinoic acid-inducible gene (RIG)-I like receptors. Signaling through these receptors induces the production of antiviral soluble factors, including interferons (IFNs), which act on adjacent healthy cells in a paracrine manner to trigger antiviral gene transcription. Activation of mediators like protein kinase R, 2&#x02032;5&#x02032;-oligoadenylate synthetase, RNaseL, cleavage and polyadenylation factor [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>] in otherwise healthy cells induces an antiviral state thereby limiting viral replication [<xref rid="B28" ref-type="bibr">28</xref>]. IFNs also induce expression of interferon-stimulated genes (like myxovirus-1) that have strong anti-influenza activity [<xref rid="B29" ref-type="bibr">29</xref>]. Furthermore, infected alveolar epithelial cells in the airway secrete proinflammatory cytokines like TNF<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, IL-6, CCL2, CCL5, CXCL8, and CXCL10 [<xref rid="B30" ref-type="bibr">30</xref>] in superfluity, which support innate immune cell recruitment [<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B31" ref-type="bibr">31</xref>] to contain viral spread. However, the production of inflammatory cytokines is not always protective as cytokine storms arise when they are secreted in excess as observed during HPAI H5N1 virus infection [<xref rid="B32" ref-type="bibr">32</xref>&#x02013;<xref rid="B34" ref-type="bibr">34</xref>] often leading to severe pneumonia and death. Secondly, phagocytosis of infected cells by antigen-presenting cells (APCs) can activate adaptive immune responses [<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B28" ref-type="bibr">28</xref>] that help to eliminate the infection.</p><p>Innate immune cells provide the first line of cellular defense to combat IAV infection. Leukocytes like neutrophils, monocytes, eosinophils, natural killer (NK) cells, innate lymphoid cells (ILCs), and <italic>&#x003b3;&#x003b4;</italic> T cells provide anti-influenza host protection by releasing preformed cytokines and granule contents that either directly or indirectly help the host to eliminate the threat posed by replicating virus. On the other hand, macrophages and dendritic cells (DCs) can phagocytose IAV-infected cells and present viral antigens to T cells, initiating adaptive immune responses including B cell-mediated humoral immunity. The aim of this review is to provide insight into the function of these innate leukocytes in immune protection and repair of damaged airways upon IAV infection.</p></sec><sec id="sec2"><title>2. Neutrophils: The First Recruits</title><p>Neutrophils are among the first innate cells to be recruited during IAV infection. Neutrophils are granulocytes derived from hematopoietic stem cells influenced by IL-3, M-CSF, and G-CSF. While neutrophils are first to respond to any noxious stimuli, their role during influenza is complex and accumulation in the lungs is impacted both by virus strain and dose [<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>]. Secretion of several chemotactic factors such as CCL3 [<xref rid="B37" ref-type="bibr">37</xref>], CXCL-1 (IL-8 in humans), and CXCL-2 [<xref rid="B38" ref-type="bibr">38</xref>] acts as chemotactic signals for neutrophil generation and recruitment. Neutrophils release MMP-9 to digest type IV collagen in the pulmonary endothelial basement membrane [<xref rid="B37" ref-type="bibr">37</xref>] and enter the lung tissue through CXCR2 engagement [<xref rid="B39" ref-type="bibr">39</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Neutropenia has been demonstrated to increase the pulmonary virus titer and mortality rate upon IAV infection [<xref rid="B40" ref-type="bibr">40</xref>] suggesting a protective role for neutrophils during influenza. Phagocytosis, release of granular contents, and production of cytokines are major effector functions of neutrophils. These granulocytes contain cationic antimicrobial peptides like defensins and cathelicidins that neutralize IAV [<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>]. Cathelicidins have anti-influenza activity <italic>in vivo</italic> through the reduction of viral replication and hindering the production of inflammatory mediators [<xref rid="B41" ref-type="bibr">41</xref>], showcasing a promising role for neutrophil antimicrobial peptides during virus infections. Furthermore, proinflammatory cytokines produced by neutrophils limit virus replication and halt progression to severe disease [<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Neutrophils are susceptible to IAV infection [<xref rid="B45" ref-type="bibr">45</xref>&#x02013;<xref rid="B47" ref-type="bibr">47</xref>], although infection has been demonstrated to be both productive (for pH1N1) [<xref rid="B48" ref-type="bibr">48</xref>] and abortive (for seasonal H1N1 and WSN33) [<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B49" ref-type="bibr">49</xref>]. These discrepancies might be related to virus subtypes/strains used. Interestingly, mice treated with <italic>&#x003b2;</italic>-defensin had reduced IAV burden and an associated reduction in neutrophils in the lungs [<xref rid="B21" ref-type="bibr">21</xref>], underscoring the importance of a prudently adjudicated immune response to host protection. Nonetheless, IAV-infected neutrophils upregulate IFNs and other antiviral factors [<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>] that limit viral replication (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>In addition to these conventional roles, neutrophils also utilize more sophisticated strategies to safeguard the host during influenza. One such scheme is the production of neutrophil extracellular traps (NETs) through NETosis, a release of web like structures of nucleic acids coated with histones [<xref rid="B50" ref-type="bibr">50</xref>] which capture viral particles [<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>] thereby preventing viral dissemination. Inflammatory mediators like TNF<italic>&#x003b1;</italic> and cathelicidins in the pulmonary environment trigger NETosis [<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Arginine in histones within NETs has differential aggregation properties for IAV wherein seasonal strains are more likely to be inhibited compared to pH1N1 [<xref rid="B55" ref-type="bibr">55</xref>]. However, mechanisms that dictate strain preferences for NETosis in response to IAV are unknown. Increased NET production, as observed in severe cases of H7N9 and pH1N1 infection [<xref rid="B56" ref-type="bibr">56</xref>], augmented damage to the pulmonary endothelia and epithelia [<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>] leading to severe pneumonia suggesting that uncontrolled NET production may contribute to disease severity.</p><p>Neutrophils were also shown to guide CD8<sup>+</sup> T cell activation and recruitment into the lungs during influenza emphasizing the reliance of adaptive immune cells on those from the innate branch. By presenting IAV antigens on the cell surface, neutrophils function as APCs to activate CD8<sup>+</sup> T cells within the lungs [<xref rid="B58" ref-type="bibr">58</xref>]. In addition, neutrophil membrane-bound CXCL12 is used as a beacon by CD8<sup>+</sup> T cells during migration into the IAV-infected lungs [<xref rid="B59" ref-type="bibr">59</xref>] (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The importance of neutrophils in innate immune defenses against IAV is well defined. Yet, uncontrolled trafficking of neutrophils as observed during infection with highly pathogenic H5N1 and 1918 pandemic IAV [<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B60" ref-type="bibr">60</xref>] results in the production of excessive reactive oxygen species [<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B62" ref-type="bibr">62</xref>] that causes oxidative stress-mediated pulmonary damage. Additionally, neutrophil CXCL12 trails can recruit CD8<sup>+</sup> T cells [<xref rid="B59" ref-type="bibr">59</xref>] in excess which may boost/perpetuate inflammation, lung damage and severe pathology through cytolysis of infected epithelia during IAV infection. Thus, the abundance of neutrophils in the IAV-infected lungs may dictate their precise role in immunoprotection or immunopathology.</p></sec><sec id="sec3"><title>3. Monocytes: Recruited in Time of Need</title><p>Monocytes, peripheral blood phagocytes, are recruited into the lungs during IAV infection. Based on cell surface receptors, CD14 and CD16, circulating human monocytes can be subdivided into three distinct subsets: classical (CD14<sup>++</sup>/CD16<sup>&#x02212;</sup>), intermediate (CD14<sup>++</sup>/CD16<sup>+</sup>), and nonclassical (CD14<sup>+</sup>/CD16<sup>++</sup>) [<xref rid="B63" ref-type="bibr">63</xref>&#x02013;<xref rid="B65" ref-type="bibr">65</xref>]. Compared to peripheral circulation (where classical monocytes are predominant), intermediate monocytes predominate in airways [<xref rid="B66" ref-type="bibr">66</xref>]. Similarly, murine monocytes (CD11b<sup>+</sup>CD115<sup>+</sup>) are divided into three subsets based on the expression of Ly6C as classical (Ly6C<sup>++</sup>), intermediate (Ly6C<sup>+</sup>), and nonclassical (Ly6C<sup>&#x02212;</sup>) [<xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B68" ref-type="bibr">68</xref>].</p><p>The recruitment of these circulatory monocytes across the endothelial/epithelial barrier into the lungs has been extensively studied [<xref rid="B69" ref-type="bibr">69</xref>]. IAV-infected alveolar macrophages and epithelial cells secrete monocyte attracting chemokines, CCL2, CCL3, and CCL5 [<xref rid="B69" ref-type="bibr">69</xref>&#x02013;<xref rid="B71" ref-type="bibr">71</xref>]. However, transepithelial migration of monocytes occurs through the CCL2/CCR2 axis, wherein CCR2-expressing monocytes move chemotactically towards CCL2 [<xref rid="B69" ref-type="bibr">69</xref>]. Interaction between monocyte integrins and endothelial adhesion molecules mediates transendothelial migration of monocytes [<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B72" ref-type="bibr">72</xref>&#x02013;<xref rid="B75" ref-type="bibr">75</xref>]. During IAV infection, monocyte transmigration across the endothelial barrier is predominantly dependent on interactions between VCAM-1 and <italic>&#x003b2;</italic>1 integrin (CD49d) and ICAM-1 interactions with <italic>&#x003b2;</italic>2 integrin (CD11a/CD18 or CD11b/CD18) [<xref rid="B69" ref-type="bibr">69</xref>] and promoted by TNF<italic>&#x003b1;</italic> secreted by infected alveolar macrophages (AMs) [<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B76" ref-type="bibr">76</xref>], integrin-associated protein (CD47) [<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B77" ref-type="bibr">77</xref>], and junctional adhesion molecule 3 [<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B78" ref-type="bibr">78</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Similar to neutrophils, monocytes are susceptible to IAV infection [<xref rid="B79" ref-type="bibr">79</xref>&#x02013;<xref rid="B81" ref-type="bibr">81</xref>] irrespective of the subset [<xref rid="B31" ref-type="bibr">31</xref>], and infection rates may vary with the IAV subtype with the highest infectivity for H5N1 and H7N9 than pH1N1 [<xref rid="B81" ref-type="bibr">81</xref>]. Virus-infected monocytes secrete inflammatory cytokines and chemokines [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B80" ref-type="bibr">80</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>) in a virus dose-dependent manner [<xref rid="B31" ref-type="bibr">31</xref>]. Infected monocytes produce large amounts of IFNs [<xref rid="B80" ref-type="bibr">80</xref>, <xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B83" ref-type="bibr">83</xref>] well known for their anti-influenza activity in addition to serving as a source for an array of cytokines and chemokines; for example, U937 promonocytic cells produce IL-1<italic>&#x003b2;</italic>, IL-8, IL-18, CCL3 [<xref rid="B82" ref-type="bibr">82</xref>], and IFN-<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic> [<xref rid="B80" ref-type="bibr">80</xref>, <xref rid="B83" ref-type="bibr">83</xref>]. Importantly, the microenvironment of infected lungs drives monocyte differentiation into macrophages and DCs (<xref ref-type="fig" rid="fig2">Figure 2</xref>) which play a pivotal role in phagocytosis of virus-infected cells thereby priming the adaptive immune system. During airway inflammation, migration and differentiation of blood monocytes contribute to the pool of pulmonary macrophages [<xref rid="B20" ref-type="bibr">20</xref>]. The absence of CD14 on monocytes/macrophages alters the immunopathogenesis during complex disease-disease interactions that occur when IAV infects hosts with underlying allergic states [<xref rid="B84" ref-type="bibr">84</xref>] suggesting that the function of each subset is regulated by the inflammatory milieu during influenza. The role of monocyte-derived macrophages in protection from IAV infection is described elsewhere [<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>].</p><p>Although monocytes provide immunoprotection against IAV infection, excessive infiltration of monocytes can induce immunopathology and mice exhibiting uncontrolled IAV replication have excessive monocyte recruitment into the lungs [<xref rid="B87" ref-type="bibr">87</xref>]. Conversely, monocyte-deficient CCR2<sup>&#x02212;/&#x02212;</sup> mice demonstrate increased survival following IAV infection [<xref rid="B87" ref-type="bibr">87</xref>&#x02013;<xref rid="B89" ref-type="bibr">89</xref>], suggesting that monocytes can drive IAV-induced host pathology. Moreover, disease severity correlates with increased monocyte-derived cytokines [<xref rid="B87" ref-type="bibr">87</xref>] which in turn leads to immunopathology. Overall, the role in immune protection or pathology is determined by the number of infiltrating monocytes and the cytokine milieu.</p></sec><sec id="sec4"><title>4. Pulmonary Macrophages: Sentinels in Command?</title><p>The pulmonary macrophage population consists of alveolar macrophages (AMs) and interstitial macrophages (IMs) [<xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B90" ref-type="bibr">90</xref>]. Macrophages are phenotypically classified as proinflammatory (M1) and anti-inflammatory (M2). This classification is best suited for monocyte-derived macrophages wherein different cytokines and growth factors are used for differentiation but not AMs [<xref rid="B86" ref-type="bibr">86</xref>]. In relation to IAV, AMs are best studied while the role of IMs is ambiguous due to phenotypic similarity with monocytes and technical difficulty in liberating them from the lung tissue [<xref rid="B91" ref-type="bibr">91</xref>]. Irrespective of lower phagocytic ability compared to AMs [<xref rid="B92" ref-type="bibr">92</xref>], owing to their location in the interstitium, IMs phagocytose pathogens that have evaded AMs thereby providing a second line of defense within the tissue. The potential antiviral activity of IMs needs to be explored further.</p><p>As tissue resident professional phagocytes that safeguard the airway against intruding pulmonary pathogens, AMs maintain lung homeostasis [<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B94" ref-type="bibr">94</xref>]. Cytokines, TGF-<italic>&#x003b2;</italic> and GM-CSF, promote differentiation of fetal monocytes into AMs [<xref rid="B95" ref-type="bibr">95</xref>&#x02013;<xref rid="B97" ref-type="bibr">97</xref>]. With a prolonged half-life of about 1-5 weeks, the AM population is primarily maintained via self-renewal [<xref rid="B98" ref-type="bibr">98</xref>&#x02013;<xref rid="B100" ref-type="bibr">100</xref>]. Pulmonary homeostasis is conserved in part by interaction of these AMs with alveolar epithelial cells (AECs). At steady state, AECs that express CD200 engage surface CD200R on AMs controlling the production of inflammatory cytokines [<xref rid="B101" ref-type="bibr">101</xref>]. However, IAV infection lowers the expression of CD200 and CD200R [<xref rid="B101" ref-type="bibr">101</xref>] compromising the CD200-CD200R axis which leads to macrophage activation and production of inflammatory mediators (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Pigs [<xref rid="B102" ref-type="bibr">102</xref>] and mice [<xref rid="B103" ref-type="bibr">103</xref>, <xref rid="B104" ref-type="bibr">104</xref>] intranasally administered with clodronate liposome to deplete AMs have higher lung virus titers and severe disease characterized by impaired clearance of surfactant proteins, cellular debris, dead cells, pulmonary edema, and inflammation [<xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B103" ref-type="bibr">103</xref>]. Moreover, transgenic mice selectively depleted of AMs exhibit severe influenza [<xref rid="B104" ref-type="bibr">104</xref>, <xref rid="B105" ref-type="bibr">105</xref>] suggesting a critical role for AMs in limiting virus-induced airway injury. However, the possible protective role of IMs may not be underestimated as they have more potent activators of antigen-specific T cells compared to AMs [<xref rid="B90" ref-type="bibr">90</xref>]. As most other leukocytes, AMs too secrete type I IFNs during IAV infection [<xref rid="B106" ref-type="bibr">106</xref>, <xref rid="B107" ref-type="bibr">107</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>). IAV infection of AMs showed species specificity where human AMs are not infected while the murine counterparts exhibit abortive infection [<xref rid="B108" ref-type="bibr">108</xref>, <xref rid="B109" ref-type="bibr">109</xref>]. Since IAVs fail to infect human AMs [<xref rid="B108" ref-type="bibr">108</xref>], an alternative mechanism like phagocytosis of apoptotic cells may also trigger AM activation and cytokine secretion during infection [<xref rid="B110" ref-type="bibr">110</xref>].</p><p>Owing to the contribution of AMs in maintaining lung tissue integrity and pulmonary homeostasis, their role in protecting AECs from IAV-induced damage is important. Type I AECs are responsible for gas exchange, and their impairment during infection leads to pulmonary dysfunction. On the other hand, type II AECs can self-renew or divide to replenish damaged type I AECs [<xref rid="B111" ref-type="bibr">111</xref>]. Engagement of CysLT, a cell surface cysteinyl leukotriene receptor on type I AEC, enhances their susceptibility to IAV infection [<xref rid="B104" ref-type="bibr">104</xref>]. However, AMs suppress the CysLT pathway in type I AEC [<xref rid="B104" ref-type="bibr">104</xref>] conferring the protection to AECs during infection. Peroxisome proliferator-activated receptor gamma (PPAR-<italic>&#x003b3;</italic>), highly expressed in AMs and critical during their development [<xref rid="B112" ref-type="bibr">112</xref>], restricts AMs from excessive proinflammatory cytokine production [<xref rid="B113" ref-type="bibr">113</xref>] thereby maintaining lung homeostasis. Parallelly, PPAR-<italic>&#x003b3;</italic> stimulation lessens IAV-associated inflammation within airways [<xref rid="B114" ref-type="bibr">114</xref>] and increases the secretion of tissue remodeling (MMP7 and MMP9) and epi-endothelial growth factors (EGF and VEGF) [<xref rid="B115" ref-type="bibr">115</xref>] suggesting a critical role for AMs as regulators of wound healing and tissue repair upon IAV infection.</p><p>The contribution of macrophages to immunopathology is evident from the fact that CCR2<sup>&#x02212;/&#x02212;</sup> mice are protected from IAV-induced pulmonary tissue destruction and mortality [<xref rid="B89" ref-type="bibr">89</xref>]. Furthermore, protective mechanisms in these macrophage deficient mice are traced to delayed migration of T cells [<xref rid="B89" ref-type="bibr">89</xref>] suggesting that macrophages alter cellular immune responses. The role of macrophages in IAV-mediated pathology is based on findings from monocyte-derived macrophages (MDMs). The induction of macrophage-derived cytokines, IFN-<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic>, TNF<italic>&#x003b1;</italic>, CCL2, CCL3, CCL5, and CXCL10, is greater for highly pathogenic H5N1 virus than seasonal influenza viruses [<xref rid="B116" ref-type="bibr">116</xref>, <xref rid="B117" ref-type="bibr">117</xref>] suggesting that these inflammatory mediators may contribute to IAV-induced immunopathology. In contrast, MDMs infected with H5N1 virus showed lower expression of cytokines, namely, IFN-<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic>, TNF<italic>&#x003b1;</italic>, CCL5, and CCL8 at early times postinfection [<xref rid="B118" ref-type="bibr">118</xref>]. This may be representative of an immune evasion strategy of IAVs to prolong uncontrolled replication and replication-induced pathology to gain a foothold in the host. Cumulatively, these observations suggest that pulmonary dysfunction observed in fatal cases of influenza depends on how macrophages respond to the invading virus.</p></sec><sec id="sec5"><title>5. Dendritic Cells: Calling for Help</title><p>Dendritic cells (DCs) are professional APCs that patrol the body surfaces (skin, gut, or airway) for intruding microbes or insults. They play a key role in host immunity by bridging innate and adaptive arms of the immune system [<xref rid="B119" ref-type="bibr">119</xref>, <xref rid="B120" ref-type="bibr">120</xref>]. DCs are broadly classified as CD11c<sup>+</sup> conventional DCs (cDCs) and CD11c<sup>&#x02212;</sup> plasmacytoid DCs (pDCs) [<xref rid="B121" ref-type="bibr">121</xref>, <xref rid="B122" ref-type="bibr">122</xref>]. Furthermore, two subsets of cDCs have been identified in the airways: CD103<sup>+</sup>CD11b<sup>&#x02212;</sup> (CD103<sup>+</sup> cDCs) and CD103<sup>&#x02212;</sup>CD11b<sup>+</sup> (CD11b<sup>+</sup> cDCs) cells [<xref rid="B123" ref-type="bibr">123</xref>]; the latter of which resides in the lamina propria which lies immediately beneath the airway epithelium [<xref rid="B124" ref-type="bibr">124</xref>, <xref rid="B125" ref-type="bibr">125</xref>]. In a steady state, the major DC population in the airway mucosa is CD103<sup>+</sup> cDCs followed by CD11b<sup>+</sup> cDCs and pDCs [<xref rid="B124" ref-type="bibr">124</xref>, <xref rid="B126" ref-type="bibr">126</xref>, <xref rid="B127" ref-type="bibr">127</xref>]. Humans also have more myeloid DCs (similar to cDCs in mice) in the airways than pDCs [<xref rid="B66" ref-type="bibr">66</xref>]. The CD103<sup>+</sup> cDCs can extend their dendrites or traverse the alveolar epithelia into the airway for surveillance and antigen capture [<xref rid="B123" ref-type="bibr">123</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Acute IAV infection leads to a decrease in cDCs and pDCs in peripheral circulation [<xref rid="B128" ref-type="bibr">128</xref>&#x02013;<xref rid="B130" ref-type="bibr">130</xref>] and a sustained increase in the respiratory tract [<xref rid="B129" ref-type="bibr">129</xref>, <xref rid="B130" ref-type="bibr">130</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>) suggesting active trafficking of DC populations during influenza. Following intranasal inoculation of IAV (X31 H3N2) in mice, pulmonary cDC subsets demonstrated sustained increase while it was transient for pDC. Moreover, draining lymph nodes (DLNs) contained only cDCs [<xref rid="B127" ref-type="bibr">127</xref>] suggesting maturation and migration of cDCs to DLNs following IAV infection (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Antimicrobial peptide, <italic>&#x003b2;</italic>-defensin, induces a reduction in lung cDCs during pH1N1 infection [<xref rid="B21" ref-type="bibr">21</xref>], emphasizing the complex interaction and dependence between the soluble and cellular factors of the innate immune system. Depletion of CD103<sup>+</sup> cDCs aggravated disease severity [<xref rid="B127" ref-type="bibr">127</xref>] suggesting a crucial role during influenza. Therefore, the totality of cDCs' contribution to lung health during IAV infection remains unknown, and since these subsets of cDCs secrete inflammatory mediators [<xref rid="B131" ref-type="bibr">131</xref>], a possible role in recruiting other leukocytes during influenza needs to be more fully explored.</p><p>Compared to other DC subsets, CD103<sup>+</sup> cDCs are highly efficient at viral antigen uptake and migration to DLNs [<xref rid="B131" ref-type="bibr">131</xref>] and are the most efficient cross-presenters of the immune system [<xref rid="B132" ref-type="bibr">132</xref>] as they differ in their antigen processing and presentation capabilities [<xref rid="B133" ref-type="bibr">133</xref>]. While CD103<sup>+</sup> cDCs process and present IAV antigens to CD8<sup>+</sup> T cells efficiently [<xref rid="B127" ref-type="bibr">127</xref>, <xref rid="B131" ref-type="bibr">131</xref>], IAV-activated CD11b<sup>+</sup> cDCs fail to prime CD8<sup>+</sup> T cells [<xref rid="B127" ref-type="bibr">127</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>). This might be related to the ability of these cells to support IAV replication <italic>ex vivo</italic>; CD103<sup>+</sup> cDCs support productive IAV infection while CD11b<sup>+</sup> cDCs do not [<xref rid="B134" ref-type="bibr">134</xref>], providing an explanation for CD103<sup>+</sup> cDC's superior antigen-presenting capacity. However, whether CD103<sup>+</sup> cDCs support IAV replication <italic>in vivo</italic> is unclear with data suggesting that viral antigen is acquired through phagocytosis instead to allow cross-presentation to CD8<sup>+</sup> T cells [<xref rid="B132" ref-type="bibr">132</xref>].</p><p>The effective function of cDCs in priming the T cell-mediated immune response depends on (1) trafficking of IAV-activated DCs into DLNs, (2) presentation of antigen to specific CD8<sup>+</sup> T cells, and (3) lung homing capacity of activated CD8<sup>+</sup> T cells. Migration of pulmonary cDCs into DLNs depends on expression of CCR7, as <italic>ccr7</italic>-deficient mice lack DC trafficking into DLNs [<xref rid="B133" ref-type="bibr">133</xref>, <xref rid="B135" ref-type="bibr">135</xref>]. Both CD103<sup>+</sup> cDCs and CD11b<sup>+</sup> cDCs express CCR7 [<xref rid="B131" ref-type="bibr">131</xref>] confirming the migratory nature of these cDCs. Once in the DLNs, these DCs prime IAV antigen-specific CD8<sup>+</sup> T cells, which migrate into infected lungs in a CCR4-dependent manner [<xref rid="B136" ref-type="bibr">136</xref>] to exert anti-influenza activity (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Following IAV infection, pDCs produce large amounts of chemoattractants, importantly CXCL1, CCL2, CCL5, and CXCL10 [<xref rid="B137" ref-type="bibr">137</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Mice selectively depleted of pDCs exhibited delayed recruitment of T cells into airways [<xref rid="B138" ref-type="bibr">138</xref>] suggesting that they regulate accumulation of T cells during early IAV infection. The ability of pDCs to support IAV replication is dose dependent [<xref rid="B139" ref-type="bibr">139</xref>, <xref rid="B140" ref-type="bibr">140</xref>]; susceptibility observed with higher multiplicity of infections (MOIs) [<xref rid="B139" ref-type="bibr">139</xref>, <xref rid="B140" ref-type="bibr">140</xref>] might not correlate with infection in humans. Since, at lower MOIs, pDCs do not support IAV replication [<xref rid="B139" ref-type="bibr">139</xref>], they fail to prime CD4<sup>+</sup> or CD8<sup>+</sup> T cells directly [<xref rid="B127" ref-type="bibr">127</xref>]. However, pDCs can uptake IAV antigens from virus-infected cells and upregulate CCR7 expression in response [<xref rid="B141" ref-type="bibr">141</xref>] suggesting that they too can migrate to DLNs and cross-present acquired IAV antigens. During IAV infection, pDCs induce differentiation of B cells into antibody-secreting plasma cells through IFN<italic>&#x003b1;</italic> and IL-6 [<xref rid="B142" ref-type="bibr">142</xref>] and the depletion of pDCs abrogates antibody secretion [<xref rid="B127" ref-type="bibr">127</xref>]. The activation of lung-resident B cells during pH1N1 infection [<xref rid="B143" ref-type="bibr">143</xref>] may be led by these DC subsets that encounter viral antigen thereby providing dual protection at the site of infection as well as by couriering a call for help (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>As with most factors of the immune response, moderation is required for health and excessive cytokine levels can be detrimental to the host. Highly pathogenic H5N1 virus-infected pDCs produce higher amounts of IFN<italic>&#x003b1;</italic> than those infected with less virulent seasonal H1N1 and H3N2 strains [<xref rid="B139" ref-type="bibr">139</xref>, <xref rid="B144" ref-type="bibr">144</xref>]. While IFN<italic>&#x003b1;</italic> secreted from pDCs does have antiviral functions [<xref rid="B139" ref-type="bibr">139</xref>, <xref rid="B145" ref-type="bibr">145</xref>] (<xref ref-type="fig" rid="fig2">Figure 2</xref>), prolific production during IAV infection results in uncontrolled inflammation and host pathology [<xref rid="B146" ref-type="bibr">146</xref>], alluding that pDCs may also contribute to the cytokine storm during infection. As an antithesis to sublethal IAV infection, lethal infection causes the accumulation of pDCs in DLNs with enhanced expression of Fas ligand (FasL) [<xref rid="B147" ref-type="bibr">147</xref>, <xref rid="B148" ref-type="bibr">148</xref>] which engages with Fas, a membrane protein of the death receptor family [<xref rid="B149" ref-type="bibr">149</xref>] expressed on IAV-specific CD8<sup>+</sup> T cells eliminating them via Fas-mediated apoptosis [<xref rid="B147" ref-type="bibr">147</xref>, <xref rid="B148" ref-type="bibr">148</xref>]. Conversely, since IAV infection in pDC-depleted mice leads to enhanced accumulation of inflammatory cells, particularly CD11b<sup>+</sup> cDCs and macrophages which produce massive amounts of proinflammatory cytokines (TNF<italic>&#x003b1;</italic> and IL-6) [<xref rid="B150" ref-type="bibr">150</xref>], pDCs may be important immunoregulators during lethal IAV infection. The protective versus deleterious effect of pDCs depends on the infectious dose.</p></sec><sec id="sec6"><title>6. Eosinophils: Additional Sources of Host Defense</title><p>Eosinophils are not usually considered mediators of anti-influenza immunity. However, epidemiologic data associated with the 2009 H1N1 pandemic suggested that asthmatics, presumably with pulmonary eosinophilia, were less likely to suffer from IAV-induced morbidity and mortality [<xref rid="B151" ref-type="bibr">151</xref>&#x02013;<xref rid="B153" ref-type="bibr">153</xref>]. Pediatric influenza patients who developed acute pneumonia demonstrated a rise in the serum IL-5 levels and peripheral eosinophilia [<xref rid="B154" ref-type="bibr">154</xref>], suggesting that eosinophil recruitment may be necessary for late-stage anti-influenza host defense. Pulmonary eosinophilia has also been documented in IAV-infected mice [<xref rid="B155" ref-type="bibr">155</xref>&#x02013;<xref rid="B158" ref-type="bibr">158</xref>] suggesting that cytokines like CCL5 [<xref rid="B30" ref-type="bibr">30</xref>] or IL-5 [<xref rid="B155" ref-type="bibr">155</xref>] produced during IAV infection may drive eosinophil migration (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Based on known functions of eosinophils during parasite infections and allergy [<xref rid="B159" ref-type="bibr">159</xref>], it may be likely that their influx into the lung during mid-late infection is in support of reparative processes required after IAV-induced cytopathology.</p><p>Eosinophils are conducive to IAV infection and undergo piecemeal degranulation in response to IAV [<xref rid="B160" ref-type="bibr">160</xref>]. This selective release of granule proteins such as major basic protein, eosinophil peroxidase, eosinophil cationic protein, and eosinophil-derived neurotoxin, in addition to immunoregulatory cytokines and chemokines [<xref rid="B161" ref-type="bibr">161</xref>, <xref rid="B162" ref-type="bibr">162</xref>] at the infection site, may either immunomodulate other leukocytes or help contain the virus <italic>in situ</italic> (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Additionally, mice suffering from acute allergy are protected from IAV-induced airway damage [<xref rid="B157" ref-type="bibr">157</xref>] suggesting that eosinophils are important mediators during anti-influenza immunity in special populations of patients such as those with a T<sub>H</sub>2 bias. Our findings that eosinophils were capable of trafficking to DLNs following IAV infection and their putative function in IAV antigen presentation in the context of MHCI to activate CD8<sup>+</sup> T cells [<xref rid="B160" ref-type="bibr">160</xref>] forecast multifaceted functions for eosinophils during influenza pathogenesis [<xref rid="B163" ref-type="bibr">163</xref>].</p></sec><sec id="sec7"><title>7. Natural Killer Cells: On-Site Killing</title><p>As large granular lymphocytes representing about 10% of lung resident lymphocytes, NK cells accumulate in the respiratory tract in response to IAV infection [<xref rid="B164" ref-type="bibr">164</xref>&#x02013;<xref rid="B167" ref-type="bibr">167</xref>]. This increase correlates with an initial decrease in circulatory NK cells [<xref rid="B166" ref-type="bibr">166</xref>, <xref rid="B168" ref-type="bibr">168</xref>] suggesting that during early IAV infection NK cells are recruited directly from blood [<xref rid="B164" ref-type="bibr">164</xref>] (<xref ref-type="fig" rid="fig3">Figure 3</xref>). NK cell recruitment to the site of infection depends on expression of chemokine receptors, namely, CCR2, CCR5, and CXCR3 [<xref rid="B164" ref-type="bibr">164</xref>, <xref rid="B167" ref-type="bibr">167</xref>, <xref rid="B169" ref-type="bibr">169</xref>] through interaction with ligands like CCL2, CCL5, CXCL9, CXCL10, and CXCL11 [<xref rid="B164" ref-type="bibr">164</xref>, <xref rid="B167" ref-type="bibr">167</xref>, <xref rid="B169" ref-type="bibr">169</xref>] (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>Primary effector functions (cytolysis of infected cells and cytokine secretion [<xref rid="B170" ref-type="bibr">170</xref>]) of IAV-stimulated NK cells are facilitated through cytotoxic receptors, NKp46, NKp44, and NKp30, of which viral HA binds directly to sialic acids expressed on NKp46 [<xref rid="B171" ref-type="bibr">171</xref>&#x02013;<xref rid="B173" ref-type="bibr">173</xref>] (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Viral subtypes may dictate the strength of NK cell activation wherein H5N1 and 1918 H1N1 viruses induce stronger responses compared to the pH1N1 virus [<xref rid="B174" ref-type="bibr">174</xref>], suggesting that the difference in receptor binding preference of the infecting virus differentially regulates NK cell activation. Cytolysis of IAV-infected cells is achieved by degranulation and release of perforin and granzyme, as well as by lytic activity of IFN<italic>&#x003b3;</italic> secreted by activated NK cells [<xref rid="B174" ref-type="bibr">174</xref>] (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>Epithelial cytopathology is a principal outcome of IAV infection of the respiratory tract which NK cells can mitigate through IL-22 production [<xref rid="B165" ref-type="bibr">165</xref>]. Airway epithelial cells expressing IL-22R [<xref rid="B175" ref-type="bibr">175</xref>] respond to IL-22 through epithelial regeneration which reduces inflammation [<xref rid="B165" ref-type="bibr">165</xref>]. This demonstrated the pivotal role of the IL-22-IL-22R axis in maintaining epithelial integrity and tissue homeostasis upon IAV infection (<xref ref-type="fig" rid="fig3">Figure 3</xref>). In vitro studies suggest that NK cell apoptosis triggered during IAV replication within these cells [<xref rid="B171" ref-type="bibr">171</xref>] may be an immune evasion strategy empoyed by IAV. Since the full spectrum of interaction between NK cells and IAV is yet to be elucidated, additional studies that focus on NK cells are warranted.</p><p>Cells that coexpress the NK cell marker and the T cell receptor, termed NKT cells, have gained more attention from influenza virologists in recent years. These cells provide immunoprotection during IAV infection by reducing inflammation, primarily the accumulation of inflammatory monocytes [<xref rid="B176" ref-type="bibr">176</xref>], reducing immunosuppressive activity of myeloid-derived suppressor cells [<xref rid="B177" ref-type="bibr">177</xref>], or through the production of IL-22 that controls lung epithelial damage [<xref rid="B178" ref-type="bibr">178</xref>].</p></sec><sec id="sec8"><title>8. Innate Lymphoid Cells: Immediate Depots of Cytokines</title><p>The ILC family consists of cytotoxic NK cells and three noncytotoxic members, ILC1, ILC2, and ILC3, that are innate counterparts of T cells that do not express antigen receptors [<xref rid="B179" ref-type="bibr">179</xref>]. Various insults activate ILC subsets; ILC1 responds to viruses and intracellular bacteria, ILC2 to extracellular parasites and allergens, and ILC3 to extracellular bacteria and fungi [<xref rid="B179" ref-type="bibr">179</xref>&#x02013;<xref rid="B182" ref-type="bibr">182</xref>].</p><p>Although ILC2s are known to provide antihelminthic immunity, recent findings demonstrate their influx into lungs following IAV infection [<xref rid="B183" ref-type="bibr">183</xref>] most likely in response to alveolar epithelial- and macrophage-derived IL-33 [<xref rid="B155" ref-type="bibr">155</xref>, <xref rid="B184" ref-type="bibr">184</xref>&#x02013;<xref rid="B187" ref-type="bibr">187</xref>] sensed through surface-expressed IL-33R [<xref rid="B188" ref-type="bibr">188</xref>] (<xref ref-type="fig" rid="fig4">Figure 4</xref>). As potent producers of IL-5, ILC2s may regulate eosinophil infiltration during influenza [<xref rid="B155" ref-type="bibr">155</xref>, <xref rid="B188" ref-type="bibr">188</xref>]. Within the lungs, ILC2s increase expression of genes encoding amphiregulin and extracellular matrix proteins asporin, decorin, and dermatopontin [<xref rid="B188" ref-type="bibr">188</xref>]. Strikingly, ILC2-derived amphiregulin is involved in tissue repair and remodeling [<xref rid="B188" ref-type="bibr">188</xref>] (<xref ref-type="fig" rid="fig4">Figure 4</xref>) suggesting that ILC2s are capable of lung tissue homeostasis during influenza. As major contributors of IFN<italic>&#x003b3;</italic>, a crucial cytokine in the anti-influenza armamentarium, ILC1s induce cytolysis of IAV-infected cells [<xref rid="B179" ref-type="bibr">179</xref>&#x02013;<xref rid="B182" ref-type="bibr">182</xref>]. However, IFN<italic>&#x003b3;</italic> can also enhance influenza disease severity possibly through suppression of ILC2 function [<xref rid="B189" ref-type="bibr">189</xref>].</p></sec><sec id="sec9"><title>9. <italic>&#x003b3;&#x003b4;</italic> T Cells: Holding Down the Fort</title><p>Innate-like T cells expressing <italic>&#x003b3;</italic> and <italic>&#x003b4;</italic> chains as receptors, <italic>&#x003b3;&#x003b4;</italic> T cells constitute around 1-5% of blood lymphocytes. Given that <italic>&#x003b3;&#x003b4;</italic> T cells respond antecedent to <italic>&#x003b1;&#x003b2;</italic> T cells during infection [<xref rid="B190" ref-type="bibr">190</xref>], they may serve a pivotal role in early-stage antiviral host defense during influenza. Intravenous adoptive transfer of <italic>&#x003b3;&#x003b4;</italic> T cells to IAV-infected mice inhibits viral replication and controls disease progression [<xref rid="B191" ref-type="bibr">191</xref>] suggesting that these cells can traffic to lungs (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Moreover, IAV-activated <italic>&#x003b3;&#x003b4;</italic> T cells express high levels of chemokine receptors CXCR5, CCR1, and CCR5 [<xref rid="B192" ref-type="bibr">192</xref>] allowing their migration towards CCL3 and CCL5 [<xref rid="B193" ref-type="bibr">193</xref>] abundant IAV-infected lungs [<xref rid="B116" ref-type="bibr">116</xref>] (<xref ref-type="fig" rid="fig4">Figure 4</xref>). As a means of self-promotion, IAV-activated <italic>&#x003b3;&#x003b4;</italic> T cells produce preferred chemokines including CCL5 [<xref rid="B192" ref-type="bibr">192</xref>] to chaperon circulatory <italic>&#x003b3;&#x003b4;</italic> T cell recruitment into the lungs. The production of CCL5 is dependent on virus subtypes (higher for avian viruses than human viruses [<xref rid="B192" ref-type="bibr">192</xref>]), indicating that infection with avian viruses promotes more robust <italic>&#x003b3;&#x003b4;</italic> T cell infiltration.</p><p>Similar to other innate lymphocytes, <italic>&#x003b3;&#x003b4;</italic> T cells exert anti-influenza activity either by direct killing [<xref rid="B194" ref-type="bibr">194</xref>, <xref rid="B195" ref-type="bibr">195</xref>] or noncytolytic inhibition of virus replication through the secretion of IFN<italic>&#x003b3;</italic> [<xref rid="B192" ref-type="bibr">192</xref>, <xref rid="B196" ref-type="bibr">196</xref>] (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The inhibition of human H1N1 virus replication is achieved by both noncytolytic and cytolytic mechanisms [<xref rid="B192" ref-type="bibr">192</xref>, <xref rid="B196" ref-type="bibr">196</xref>]. In contrast, avian IAVs are resistant to the antiviral activity of IFN<italic>&#x003b3;</italic>. The cytotoxicity of <italic>&#x003b3;&#x003b4;</italic> T cells involves cytolytic granules (perforin and granzymes), NKG2D, TRAIL, and Fas-FasL pathways [<xref rid="B194" ref-type="bibr">194</xref>, <xref rid="B195" ref-type="bibr">195</xref>]. Furthermore, <italic>&#x003b3;&#x003b4;</italic> T cells effectively kill cells infected with various IAV subtypes [<xref rid="B192" ref-type="bibr">192</xref>, <xref rid="B195" ref-type="bibr">195</xref>, <xref rid="B196" ref-type="bibr">196</xref>] suggesting their role in the heterosubtypic immune response. It has been argued that IAV-infected macrophages and sentinel DCs alter the mevalonate pathway which in turn liberates isopentyl pyrophosphate (IPP), an antigen for <italic>&#x003b3;&#x003b4;</italic> T cells [<xref rid="B196" ref-type="bibr">196</xref>]. The production of IPP activates <italic>&#x003b3;&#x003b4;</italic> T cells, thereby conferring immune protection independent of incoming virus subtypes.</p><p>Subtypes of IAV differ in the degree of disease severity they elicit in the host. Apart from engaging the T cell receptor, IAV HA protein activates <italic>&#x003b3;&#x003b4;</italic> T cells [<xref rid="B197" ref-type="bibr">197</xref>, <xref rid="B198" ref-type="bibr">198</xref>] through <italic>&#x003b1;</italic>-2,3 and <italic>&#x003b1;</italic>-2,6 sialic acid receptor engagement on the cell surface [<xref rid="B198" ref-type="bibr">198</xref>] suggesting that HA-mediated differential activation of <italic>&#x003b3;&#x003b4;</italic> T cells might be related to the degree of protection provided by these immune cells to IAVs with different sialic acid preferences.</p><p>The rapid secretion of IL-17A by <italic>&#x003b3;&#x003b4;</italic> T cells from neonatal mice promotes AECs to produce IL-33 (<xref ref-type="fig" rid="fig4">Figure 4</xref>), protecting neonates from severe influenza [<xref rid="B199" ref-type="bibr">199</xref>]. Since <italic>&#x003b3;&#x003b4;</italic> T cell-mediated IL-33 production serves as a cue for IL-33R expressing ILC recruitment [<xref rid="B188" ref-type="bibr">188</xref>], which in turn promotes tissue repair through amphiregulin secretion [<xref rid="B199" ref-type="bibr">199</xref>], the complex cell-cell interactions that occur even in the innate cell compartment of the immune system are necessary and important to anti-influenza host protection (<xref ref-type="fig" rid="fig4">Figure 4</xref>). These observations suggested that IL-17A and the timing of its release can modulate the balance between protection and pathogenicity in a host infected with IAV.</p></sec><sec id="sec10"><title>10. Conclusion</title><p>Despite annual vaccination strategies, IAV infections pose a continuous threat to human health. Development of better therapeutic options is required to tackle the growing burden of IAV infections. This requires a thorough understanding of virus pathogenesis and contribution of immediate responders during infection. Innate immune cells are critical to primary immunity against IAV infection at the respiratory barrier. However, the balance between innate immune cell-induced protection and pathology is governed by their abundance, the potency of secreted immune mediators, infecting viral strain/subtype, and immune status of the host (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Hence, the identification of key regulators in innate leukocytes that mediate protection against IAV may provide broader options for therapeutic interventions.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank Samarasinghe Group members, Kim LeMessurier, Maneesha Palipane, and Meenakshi Tiwary, for their comments and feedback on the manuscript. This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01-AI125481 to AES.</p></ack><sec><title>Disclosure</title><p>The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors have no conflict of interest to declare.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>T.</given-names></name></person-group><article-title>Laboratory epidemiology of respiratory viruses in a large children&#x02019;s hospital</article-title><source><italic toggle="yes">Medicine</italic></source><year>2018</year><volume>97</volume><issue>30, article e11385</issue><pub-id pub-id-type="doi">10.1097/MD.0000000000011385</pub-id><pub-id pub-id-type="other">2-s2.0-85050764324</pub-id><?supplied-pmid 30045260?><pub-id pub-id-type="pmid">30045260</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaunt</surname><given-names>E. R.</given-names></name><name><surname>Harvala</surname><given-names>H.</given-names></name><name><surname>McIntyre</surname><given-names>C.</given-names></name><name><surname>Templeton</surname><given-names>K. E.</given-names></name><name><surname>Simmonds</surname><given-names>P.</given-names></name></person-group><article-title>Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model</article-title><source><italic toggle="yes">Journal of Clinical Virology</italic></source><year>2011</year><volume>52</volume><issue>3</issue><fpage>215</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2011.07.017</pub-id><pub-id pub-id-type="other">2-s2.0-80054684521</pub-id><?supplied-pmid 21880543?><pub-id pub-id-type="pmid">21880543</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visseaux</surname><given-names>B.</given-names></name><name><surname>Burdet</surname><given-names>C.</given-names></name><name><surname>Voiriot</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2017</year><volume>12</volume><issue>7, article e0180888</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0180888</pub-id><pub-id pub-id-type="other">2-s2.0-85023776328</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karron</surname><given-names>R. A.</given-names></name><name><surname>Black</surname><given-names>R. E.</given-names></name></person-group><article-title>Determining the burden of respiratory syncytial virus disease: the known and the unknown</article-title><source><italic toggle="yes">The Lancet</italic></source><year>2017</year><volume>390</volume><issue>10098</issue><fpage>917</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)31476-9</pub-id><pub-id pub-id-type="other">2-s2.0-85021884867</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>S. E.</given-names></name><name><surname>Lamson</surname><given-names>D. M.</given-names></name><name><surname>St. George</surname><given-names>K.</given-names></name><name><surname>Walsh</surname><given-names>T. J.</given-names></name></person-group><article-title>Human rhinoviruses</article-title><source><italic toggle="yes">Clinical Microbiology Reviews</italic></source><year>2013</year><volume>26</volume><issue>1</issue><fpage>135</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1128/CMR.00077-12</pub-id><pub-id pub-id-type="other">2-s2.0-84872196374</pub-id><?supplied-pmid 23297263?><pub-id pub-id-type="pmid">23297263</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Knipe</surname><given-names>D. M.</given-names></name><name><surname>Howley</surname><given-names>P. M.</given-names></name><name><surname>Griffin</surname><given-names>D. E.</given-names></name><name><surname>Knipe</surname></name><name><surname>Howley</surname></name></person-group><person-group person-group-type="editor"><name><surname>Wright</surname><given-names>P.</given-names></name><name><surname>Neumann</surname><given-names>G.</given-names></name><name><surname>Kawaoka</surname><given-names>Y.</given-names></name></person-group><article-title>Fields virology</article-title><source><italic toggle="yes">Orthomyxoviruses</italic></source><year>2013</year><edition>6th</edition><publisher-loc>Philadelphia, PA, USA</publisher-loc><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><fpage>1186</fpage><lpage>1243</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="book"><collab>World Health Organization</collab><source><italic toggle="yes">Influenza (Seasonal)</italic></source><year>2018</year><publisher-loc>Geneva</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J. F.-W.</given-names></name><name><surname>To</surname><given-names>K. K. W.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Yuen</surname><given-names>K. Y.</given-names></name></person-group><article-title>Cross-species transmission and emergence of novel viruses from birds</article-title><source><italic toggle="yes">Current Opinion in Virology</italic></source><year>2015</year><volume>10</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2015.01.006</pub-id><pub-id pub-id-type="other">2-s2.0-84921946578</pub-id><?supplied-pmid 25644327?><pub-id pub-id-type="pmid">25644327</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webster</surname><given-names>R. G.</given-names></name><name><surname>Govorkova</surname><given-names>E. A.</given-names></name></person-group><article-title>Continuing challenges in influenza</article-title><source><italic toggle="yes">Annals of the New York Academy of Sciences</italic></source><year>2014</year><volume>1323</volume><issue>1</issue><fpage>115</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1111/nyas.12462</pub-id><pub-id pub-id-type="other">2-s2.0-84907954836</pub-id><pub-id pub-id-type="pmid">24891213</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>New world bats harbor diverse influenza A viruses</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2013</year><volume>9</volume><issue>10, article e1003657</issue><pub-id pub-id-type="doi">10.1371/journal.ppat.1003657</pub-id><pub-id pub-id-type="other">2-s2.0-84887290174</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caini</surname><given-names>S.</given-names></name><name><surname>Kroneman</surname><given-names>M.</given-names></name><name><surname>Wiegers</surname><given-names>T.</given-names></name><name><surname>el Guerche-S&#x000e9;blain</surname><given-names>C.</given-names></name><name><surname>Paget</surname><given-names>J.</given-names></name></person-group><article-title>Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: a systematic literature review</article-title><source><italic toggle="yes">Influenza and Other Respiratory Viruses</italic></source><year>2018</year><volume>12</volume><issue>6</issue><fpage>780</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1111/irv.12575</pub-id><pub-id pub-id-type="other">2-s2.0-85050355744</pub-id><?supplied-pmid 29858537?><pub-id pub-id-type="pmid">29858537</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Presanis</surname><given-names>A. M.</given-names></name><name><surname>Bond</surname><given-names>H. S.</given-names></name><name><surname>Lau</surname><given-names>E. H. Y.</given-names></name><name><surname>Fang</surname><given-names>V. J.</given-names></name><name><surname>Cowling</surname><given-names>B. J.</given-names></name></person-group><article-title>A joint analysis of influenza-associated hospitalizations and mortality in Hong Kong, 1998-2013</article-title><source><italic toggle="yes">Scientific Reports</italic></source><year>2017</year><volume>7</volume><issue>1</issue><fpage>p. 929</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-01021-x</pub-id><pub-id pub-id-type="other">2-s2.0-85018184597</pub-id><?supplied-pmid 28428558?><pub-id pub-id-type="pmid">28428558</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daley</surname><given-names>A.</given-names></name><name><surname>Nallusamy</surname><given-names>R.</given-names></name><name><surname>Isaacs</surname><given-names>D.</given-names></name></person-group><article-title>Comparison of influenza A and influenza B virus infection in hospitalized children</article-title><source><italic toggle="yes">Journal of Paediatrics and Child Health</italic></source><year>2000</year><volume>36</volume><issue>4</issue><fpage>332</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1754.2000.00533.x</pub-id><pub-id pub-id-type="other">2-s2.0-0033861563</pub-id><?supplied-pmid 10940165?><pub-id pub-id-type="pmid">10940165</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>N. J.</given-names></name><name><surname>Subbarao</surname><given-names>K.</given-names></name></person-group><article-title>Global epidemiology of influenza: past and present</article-title><source><italic toggle="yes">Annual Review of Medicine</italic></source><year>2000</year><volume>51</volume><issue>1</issue><fpage>407</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1146/annurev.med.51.1.407</pub-id><pub-id pub-id-type="other">2-s2.0-0034051550</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalthoff</surname><given-names>D.</given-names></name><name><surname>Globig</surname><given-names>A.</given-names></name><name><surname>Beer</surname><given-names>M.</given-names></name></person-group><article-title>(Highly pathogenic) avian influenza as a zoonotic agent</article-title><source><italic toggle="yes">Veterinary Microbiology</italic></source><year>2010</year><volume>140</volume><issue>3-4</issue><fpage>237</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2009.08.022</pub-id><pub-id pub-id-type="other">2-s2.0-73949146375</pub-id><pub-id pub-id-type="pmid">19782482</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S. S. Y.</given-names></name><name><surname>Yuen</surname><given-names>K.</given-names></name></person-group><article-title>Avian influenza virus infections in humans</article-title><source><italic toggle="yes">Chest</italic></source><year>2006</year><volume>129</volume><issue>1</issue><fpage>156</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1378/chest.129.1.156</pub-id><pub-id pub-id-type="other">2-s2.0-33144461911</pub-id><pub-id pub-id-type="pmid">16424427</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="book"><collab>World Health Organization</collab><source><italic toggle="yes">Influenza at the Human-Animal Interface: Monthly Risk Assessment and Summary</italic></source><year>2019</year><publisher-loc>Geneva</publisher-loc><publisher-name>WHO</publisher-name></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>J. K.</given-names></name><name><surname>Morens</surname><given-names>D. M.</given-names></name></person-group><article-title>1918 influenza: the mother of all pandemics</article-title><source><italic toggle="yes">Emerging Infectious Diseases</italic></source><year>2006</year><volume>12</volume><issue>1</issue><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.3201/eid1209.05-0979</pub-id><pub-id pub-id-type="other">2-s2.0-31344482504</pub-id><pub-id pub-id-type="pmid">16494711</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonsen</surname><given-names>L.</given-names></name><name><surname>Spreeuwenberg</surname><given-names>P.</given-names></name><name><surname>Lustig</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study</article-title><source><italic toggle="yes">PLoS Medicine</italic></source><year>2013</year><volume>10</volume><issue>11, article e1001558</issue><pub-id pub-id-type="doi">10.1371/journal.pmed.1001558</pub-id><pub-id pub-id-type="other">2-s2.0-84889074313</pub-id><?supplied-pmid 24302890?><pub-id pub-id-type="pmid">24302890</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreijtz</surname><given-names>J. H. C. M.</given-names></name><name><surname>Fouchier</surname><given-names>R. A. M.</given-names></name><name><surname>Rimmelzwaan</surname><given-names>G. F.</given-names></name></person-group><article-title>Immune responses to influenza virus infection</article-title><source><italic toggle="yes">Virus Research</italic></source><year>2011</year><volume>162</volume><issue>1-2</issue><fpage>19</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2011.09.022</pub-id><pub-id pub-id-type="other">2-s2.0-81555228707</pub-id><pub-id pub-id-type="pmid">21963677</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeMessurier</surname><given-names>K. S.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>McCullers</surname><given-names>J. A.</given-names></name><name><surname>Samarasinghe</surname><given-names>A. E.</given-names></name></person-group><article-title>Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice</article-title><source><italic toggle="yes">Antiviral Research</italic></source><year>2016</year><volume>133</volume><fpage>208</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2016.08.013</pub-id><pub-id pub-id-type="other">2-s2.0-84983246876</pub-id><pub-id pub-id-type="pmid">27531368</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>W.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Visualizing influenza virus infection in living mice</article-title><source><italic toggle="yes">Nature Communications</italic></source><year>2013</year><volume>4</volume><issue>1, article 2369</issue><pub-id pub-id-type="doi">10.1038/ncomms3369</pub-id><pub-id pub-id-type="other">2-s2.0-84893354829</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manicassamy</surname><given-names>B.</given-names></name><name><surname>Manicassamy</surname><given-names>S.</given-names></name><name><surname>Belicha-Villanueva</surname><given-names>A.</given-names></name><name><surname>Pisanelli</surname><given-names>G.</given-names></name><name><surname>Pulendran</surname><given-names>B.</given-names></name><name><surname>Garcia-Sastre</surname><given-names>A.</given-names></name></person-group><article-title>Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus</article-title><source><italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2010</year><volume>107</volume><issue>25</issue><fpage>11531</fpage><lpage>11536</lpage><pub-id pub-id-type="doi">10.1073/pnas.0914994107</pub-id><pub-id pub-id-type="other">2-s2.0-77954889069</pub-id><pub-id pub-id-type="pmid">20534532</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tse</surname><given-names>H.</given-names></name><name><surname>To</surname><given-names>K. K. W.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2011</year><volume>6</volume><issue>9, article e22534</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0022534</pub-id><pub-id pub-id-type="other">2-s2.0-80053206038</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>J. K.</given-names></name><name><surname>Morens</surname><given-names>D. M.</given-names></name></person-group><article-title>The pathology of influenza virus infections</article-title><source><italic toggle="yes">Annual Review of Pathology</italic></source><year>2008</year><volume>3</volume><issue>1</issue><fpage>499</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1146/annurev.pathmechdis.3.121806.154316</pub-id><pub-id pub-id-type="other">2-s2.0-41749124757</pub-id><?supplied-pmid 18039138?><pub-id pub-id-type="pmid">18039138</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hale</surname><given-names>B. G.</given-names></name><name><surname>Randall</surname><given-names>R. E.</given-names></name><name><surname>Ortin</surname><given-names>J.</given-names></name><name><surname>Jackson</surname><given-names>D.</given-names></name></person-group><article-title>The multifunctional NS1 protein of influenza A viruses</article-title><source><italic toggle="yes">The Journal of General Virology</italic></source><year>2008</year><volume>89</volume><issue>10</issue><fpage>2359</fpage><lpage>2376</lpage><pub-id pub-id-type="doi">10.1099/vir.0.2008/004606-0</pub-id><pub-id pub-id-type="other">2-s2.0-54449099369</pub-id><pub-id pub-id-type="pmid">18796704</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochs</surname><given-names>G.</given-names></name><name><surname>Garcia-Sastre</surname><given-names>A.</given-names></name><name><surname>Martinez-Sobrido</surname><given-names>L.</given-names></name></person-group><article-title>Multiple anti-interferon actions of the influenza A virus NS1 protein</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2007</year><volume>81</volume><issue>13</issue><fpage>7011</fpage><lpage>7021</lpage><pub-id pub-id-type="doi">10.1128/JVI.02581-06</pub-id><pub-id pub-id-type="other">2-s2.0-34250810666</pub-id><pub-id pub-id-type="pmid">17442719</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Goraya</surname><given-names>M. U.</given-names></name><name><surname>Maarouf</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>J. L.</given-names></name></person-group><article-title>Host immune response to influenza A virus infection</article-title><source><italic toggle="yes">Frontiers in Immunology</italic></source><year>2018</year><volume>9</volume><fpage>p. 320</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00320</pub-id><pub-id pub-id-type="other">2-s2.0-85042798206</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haller</surname><given-names>O.</given-names></name><name><surname>Kochs</surname><given-names>G.</given-names></name></person-group><article-title>Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity</article-title><source><italic toggle="yes">Journal of Interferon &#x00026; Cytokine Research</italic></source><year>2011</year><volume>31</volume><issue>1</issue><fpage>79</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1089/jir.2010.0076</pub-id><pub-id pub-id-type="other">2-s2.0-78651515640</pub-id><pub-id pub-id-type="pmid">21166595</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsukura</surname><given-names>S.</given-names></name><name><surname>Kokubu</surname><given-names>F.</given-names></name><name><surname>Kubo</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Expression of RANTES by normal airway epithelial cells after influenza virus A infection</article-title><source><italic toggle="yes">American Journal of Respiratory Cell and Molecular Biology</italic></source><year>1998</year><volume>18</volume><issue>2</issue><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1165/ajrcmb.18.2.2822</pub-id><pub-id pub-id-type="other">2-s2.0-0031991488</pub-id><pub-id pub-id-type="pmid">9476913</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeve</surname><given-names>M. A.</given-names></name><name><surname>Nash</surname><given-names>A. A.</given-names></name><name><surname>Jackson</surname><given-names>D.</given-names></name><name><surname>Randall</surname><given-names>R. E.</given-names></name><name><surname>Dransfield</surname><given-names>I.</given-names></name></person-group><article-title>Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2012</year><volume>7</volume><issue>1, article e29443</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0029443</pub-id><pub-id pub-id-type="other">2-s2.0-84855388904</pub-id><?supplied-pmid 22238612?><pub-id pub-id-type="pmid">22238612</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>M. D.</given-names></name><name><surname>Simmons</surname><given-names>C. P.</given-names></name><name><surname>Thanh</surname><given-names>T. T.</given-names></name><etal/></person-group><article-title>Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia</article-title><source><italic toggle="yes">Nature Medicine</italic></source><year>2006</year><volume>12</volume><issue>10</issue><fpage>1203</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1038/nm1477</pub-id><pub-id pub-id-type="other">2-s2.0-33749511112</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>J. S. M.</given-names></name><name><surname>Yu</surname><given-names>W. C.</given-names></name><name><surname>Leung</surname><given-names>C. W.</given-names></name><etal/></person-group><article-title>Re-emergence of fatal human influenza A subtype H5N1 disease</article-title><source><italic toggle="yes">The Lancet</italic></source><year>2004</year><volume>363</volume><issue>9409</issue><fpage>617</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(04)15595-5</pub-id><pub-id pub-id-type="other">2-s2.0-10744231351</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>To</surname><given-names>K. F.</given-names></name><name><surname>Chan</surname><given-names>P. K. S.</given-names></name><name><surname>Chan</surname><given-names>K. F.</given-names></name><etal/></person-group><article-title>Pathology of fatal human infection associated with avian influenza A H5N1 virus</article-title><source><italic toggle="yes">Journal of Medical Virology</italic></source><year>2001</year><volume>63</volume><issue>3</issue><fpage>242</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1002/1096-9071(200103)63:3&#x0003c;242::AID-JMV1007&#x0003e;3.0.CO;2-N</pub-id><pub-id pub-id-type="pmid">11170064</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>M. D.</given-names></name><name><surname>Ioannidis</surname><given-names>L. J.</given-names></name><name><surname>Croker</surname><given-names>B.</given-names></name><name><surname>Brown</surname><given-names>L. E.</given-names></name><name><surname>Brooks</surname><given-names>A. G.</given-names></name><name><surname>Reading</surname><given-names>P. C.</given-names></name></person-group><article-title>The role of neutrophils during mild and severe influenza virus infections of mice</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2011</year><volume>6</volume><issue>3, article e17618</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0017618</pub-id><pub-id pub-id-type="other">2-s2.0-79952634012</pub-id><?supplied-pmid 21423798?><pub-id pub-id-type="pmid">21423798</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>M. D.</given-names></name><name><surname>Brooks</surname><given-names>A. G.</given-names></name><name><surname>Reading</surname><given-names>P. C.</given-names></name></person-group><article-title>The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice</article-title><source><italic toggle="yes">Respiratory Research</italic></source><year>2008</year><volume>9</volume><issue>1</issue><fpage>p. 57</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-9-57</pub-id><pub-id pub-id-type="other">2-s2.0-52649136695</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>L. M.</given-names></name><name><surname>Douglass</surname><given-names>M. F.</given-names></name><name><surname>Chatterjee</surname><given-names>D.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name><name><surname>Baaten</surname><given-names>B. J. G.</given-names></name></person-group><article-title>Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2012</year><volume>8</volume><issue>4, article e1002641</issue><pub-id pub-id-type="doi">10.1371/journal.ppat.1002641</pub-id><pub-id pub-id-type="other">2-s2.0-84861217128</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayden</surname><given-names>F. G.</given-names></name><name><surname>Fritz</surname><given-names>R.</given-names></name><name><surname>Lobo</surname><given-names>M. C.</given-names></name><name><surname>Alvord</surname><given-names>W.</given-names></name><name><surname>Strober</surname><given-names>W.</given-names></name><name><surname>Straus</surname><given-names>S. E.</given-names></name></person-group><article-title>Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense</article-title><source><italic toggle="yes">The Journal of Clinical Investigation</italic></source><year>1998</year><volume>101</volume><issue>3</issue><fpage>643</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1172/JCI1355</pub-id><pub-id pub-id-type="other">2-s2.0-0032005791</pub-id><?supplied-pmid 9449698?><pub-id pub-id-type="pmid">9449698</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wareing</surname><given-names>M. D.</given-names></name><name><surname>Shea</surname><given-names>A. L.</given-names></name><name><surname>Inglis</surname><given-names>C. A.</given-names></name><name><surname>Dias</surname><given-names>P. B.</given-names></name><name><surname>Sarawar</surname><given-names>S. R.</given-names></name></person-group><article-title>CXCR2 is required for neutrophil recruitment to the lung during influenza virus infection, but is not essential for viral clearance</article-title><source><italic toggle="yes">Viral Immunology</italic></source><year>2007</year><volume>20</volume><issue>3</issue><fpage>369</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1089/vim.2006.0101</pub-id><pub-id pub-id-type="other">2-s2.0-35348917816</pub-id><pub-id pub-id-type="pmid">17931107</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujisawa</surname><given-names>H.</given-names></name></person-group><article-title>Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2008</year><volume>82</volume><issue>6</issue><fpage>2772</fpage><lpage>2783</lpage><pub-id pub-id-type="doi">10.1128/JVI.01210-07</pub-id><pub-id pub-id-type="other">2-s2.0-40149092647</pub-id><pub-id pub-id-type="pmid">18184718</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlow</surname><given-names>P. G.</given-names></name><name><surname>Svoboda</surname><given-names>P.</given-names></name><name><surname>Mackellar</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2011</year><volume>6</volume><issue>10, article e25333</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0025333</pub-id><pub-id pub-id-type="other">2-s2.0-80054841451</pub-id><?supplied-pmid 22031815?><pub-id pub-id-type="pmid">22031815</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daher</surname><given-names>K. A.</given-names></name><name><surname>Selsted</surname><given-names>M. E.</given-names></name><name><surname>Lehrer</surname><given-names>R. I.</given-names></name></person-group><article-title>Direct inactivation of viruses by human granulocyte defensins</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>1986</year><volume>60</volume><issue>3</issue><fpage>1068</fpage><lpage>1074</lpage><?supplied-pmid 3023659?><pub-id pub-id-type="pmid">3023659</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>M. D.</given-names></name><name><surname>Deng</surname><given-names>Y. M.</given-names></name><name><surname>Jones</surname><given-names>J. E.</given-names></name><name><surname>Anderson</surname><given-names>G. P.</given-names></name><name><surname>Brooks</surname><given-names>A. G.</given-names></name><name><surname>Reading</surname><given-names>P. C.</given-names></name></person-group><article-title>Neutrophils ameliorate lung injury and the development of severe disease during influenza infection</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2009</year><volume>183</volume><issue>11</issue><fpage>7441</fpage><lpage>7450</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902497</pub-id><pub-id pub-id-type="other">2-s2.0-73349124131</pub-id><?supplied-pmid 19917678?><pub-id pub-id-type="pmid">19917678</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrone</surname><given-names>L. A.</given-names></name><name><surname>Plowden</surname><given-names>J. K.</given-names></name><name><surname>Garc&#x000ed;a-Sastre</surname><given-names>A.</given-names></name><name><surname>Katz</surname><given-names>J. M.</given-names></name><name><surname>Tumpey</surname><given-names>T. M.</given-names></name></person-group><article-title>H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2008</year><volume>4</volume><issue>8, article e1000115</issue><pub-id pub-id-type="doi">10.1371/journal.ppat.1000115</pub-id><pub-id pub-id-type="other">2-s2.0-50849097044</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malachowa</surname><given-names>N.</given-names></name><name><surname>Freedman</surname><given-names>B.</given-names></name><name><surname>Sturdevant</surname><given-names>D. E.</given-names></name><etal/></person-group><article-title>Differential ability of pandemic and seasonal H1N1 influenza A viruses to alter the function of human neutrophils</article-title><source><italic toggle="yes">mSphere</italic></source><year>2018</year><volume>3</volume><issue>1</issue><pub-id pub-id-type="doi">10.1128/mSphereDirect.00567-17</pub-id><?supplied-pmid 29299535?><pub-id pub-id-type="pmid">29299535</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivan</surname><given-names>F. X.</given-names></name><name><surname>Tan</surname><given-names>K. S.</given-names></name><name><surname>Phoon</surname><given-names>M. C.</given-names></name><etal/></person-group><article-title>Neutrophils infected with highly virulent influenza H3N2 virus exhibit augmented early cell death and rapid induction of type I interferon signaling pathways</article-title><source><italic toggle="yes">Genomics</italic></source><year>2013</year><volume>101</volume><issue>2</issue><fpage>101</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.ygeno.2012.11.008</pub-id><pub-id pub-id-type="other">2-s2.0-84876156376</pub-id><?supplied-pmid 23195410?><pub-id pub-id-type="pmid">23195410</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Lau</surname><given-names>L. T.</given-names></name><etal/></person-group><article-title>Neutrophils may be a vehicle for viral replication and dissemination in human H5N1 avian influenza</article-title><source><italic toggle="yes">Clinical Infectious Diseases</italic></source><year>2008</year><volume>47</volume><issue>12</issue><fpage>1575</fpage><lpage>1578</lpage><pub-id pub-id-type="doi">10.1086/593196</pub-id><pub-id pub-id-type="other">2-s2.0-56749154067</pub-id><pub-id pub-id-type="pmid">18990065</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Infectious progeny of 2009 A (H1N1) influenza virus replicated in and released from human neutrophils</article-title><source><italic toggle="yes">Scientific Reports</italic></source><year>2015</year><volume>5</volume><issue>1, article 17809</issue><pub-id pub-id-type="doi">10.1038/srep17809</pub-id><pub-id pub-id-type="other">2-s2.0-84949552722</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassidy</surname><given-names>L. F.</given-names></name><name><surname>Lyles</surname><given-names>D. S.</given-names></name><name><surname>Abramson</surname><given-names>J. S.</given-names></name></person-group><article-title>Synthesis of viral proteins in polymorphonuclear leukocytes infected with influenza A virus</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>1988</year><volume>26</volume><issue>7</issue><fpage>1267</fpage><lpage>1270</lpage><?supplied-pmid 3045149?><pub-id pub-id-type="pmid">3045149</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yipp</surname><given-names>B. G.</given-names></name><name><surname>Kubes</surname><given-names>P.</given-names></name></person-group><article-title>NETosis: how vital is it?</article-title><source><italic toggle="yes">Blood</italic></source><year>2013</year><volume>122</volume><issue>16</issue><fpage>2784</fpage><lpage>2794</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-04-457671</pub-id><pub-id pub-id-type="other">2-s2.0-84891505072</pub-id><pub-id pub-id-type="pmid">24009232</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenne</surname><given-names>C. N.</given-names></name><name><surname>Wong</surname><given-names>C. H. Y.</given-names></name><name><surname>Zemp</surname><given-names>F. J.</given-names></name><etal/></person-group><article-title>Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps</article-title><source><italic toggle="yes">Cell Host &#x00026; Microbe</italic></source><year>2013</year><volume>13</volume><issue>2</issue><fpage>169</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.01.005</pub-id><pub-id pub-id-type="other">2-s2.0-84873918079</pub-id><pub-id pub-id-type="pmid">23414757</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>T.</given-names></name><name><surname>Komano</surname><given-names>J.</given-names></name><name><surname>Saitoh</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1</article-title><source><italic toggle="yes">Cell Host &#x00026; Microbe</italic></source><year>2012</year><volume>12</volume><issue>1</issue><fpage>109</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.05.015</pub-id><?supplied-pmid 22817992?><pub-id pub-id-type="pmid">22817992</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemmers</surname><given-names>S.</given-names></name><name><surname>Teijaro</surname><given-names>J. R.</given-names></name><name><surname>Arandjelovic</surname><given-names>S.</given-names></name><name><surname>Mowen</surname><given-names>K. A.</given-names></name></person-group><article-title>PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2011</year><volume>6</volume><issue>7, article e22043</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0022043</pub-id><pub-id pub-id-type="other">2-s2.0-79960144716</pub-id><?supplied-pmid 21779371?><pub-id pub-id-type="pmid">21779371</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>S.</given-names></name><name><surname>Verma</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>E. J.</given-names></name><name><surname>White</surname><given-names>M. R.</given-names></name><name><surname>Hartshorn</surname><given-names>K. L.</given-names></name></person-group><article-title>LL-37 modulates human neutrophil responses to influenza A virus</article-title><source><italic toggle="yes">Journal of Leukocyte Biology</italic></source><year>2014</year><volume>96</volume><issue>5</issue><fpage>931</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1189/jlb.4A1113-604RR</pub-id><pub-id pub-id-type="other">2-s2.0-84908302078</pub-id><?supplied-pmid 25082153?><pub-id pub-id-type="pmid">25082153</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeksema</surname><given-names>M.</given-names></name><name><surname>Tripathi</surname><given-names>S.</given-names></name><name><surname>White</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Arginine-rich histones have strong antiviral activity for influenza A viruses</article-title><source><italic toggle="yes">Innate Immunity</italic></source><year>2015</year><volume>21</volume><issue>7</issue><fpage>736</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1177/1753425915593794</pub-id><pub-id pub-id-type="other">2-s2.0-84942114244</pub-id><?supplied-pmid 26138524?><pub-id pub-id-type="pmid">26138524</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza A infection</article-title><source><italic toggle="yes">The Journal of Infectious Diseases</italic></source><year>2018</year><volume>217</volume><issue>3</issue><fpage>428</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1093/infdis/jix475</pub-id><pub-id pub-id-type="other">2-s2.0-85041178597</pub-id><pub-id pub-id-type="pmid">29325098</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narasaraju</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>E.</given-names></name><name><surname>Samy</surname><given-names>R. P.</given-names></name><etal/></person-group><article-title>Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis</article-title><source><italic toggle="yes">The American Journal of Pathology</italic></source><year>2011</year><volume>179</volume><issue>1</issue><fpage>199</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2011.03.013</pub-id><pub-id pub-id-type="other">2-s2.0-80052510176</pub-id><pub-id pub-id-type="pmid">21703402</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hufford</surname><given-names>M. M.</given-names></name><name><surname>Richardson</surname><given-names>G.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8<sup>+</sup> T cells</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2012</year><volume>7</volume><issue>10, article e46581</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0046581</pub-id><pub-id pub-id-type="other">2-s2.0-84867322956</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>K.</given-names></name><name><surname>Hyun</surname><given-names>Y. M.</given-names></name><name><surname>Lambert-Emo</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Neutrophil trails guide influenza-specific CD8<sup>+</sup> T cells in the airways</article-title><source><italic toggle="yes">Science</italic></source><year>2015</year><volume>349</volume><issue>6252, article aaa4352</issue><pub-id pub-id-type="doi">10.1126/science.aaa4352</pub-id><pub-id pub-id-type="other">2-s2.0-84941104577</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumpey</surname><given-names>T. M.</given-names></name><name><surname>Garcia-Sastre</surname><given-names>A.</given-names></name><name><surname>Taubenberger</surname><given-names>J. K.</given-names></name><etal/></person-group><article-title>Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2005</year><volume>79</volume><issue>23</issue><fpage>14933</fpage><lpage>14944</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.23.14933-14944.2005</pub-id><pub-id pub-id-type="other">2-s2.0-27744598497</pub-id><?supplied-pmid 16282492?><pub-id pub-id-type="pmid">16282492</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yatmaz</surname><given-names>S.</given-names></name><name><surname>Seow</surname><given-names>H. J.</given-names></name><name><surname>Gualano</surname><given-names>R. C.</given-names></name><etal/></person-group><article-title>Glutathione peroxidase-1 reduces influenza A virus-induced lung inflammation</article-title><source><italic toggle="yes">American Journal of Respiratory Cell and Molecular Biology</italic></source><year>2013</year><volume>48</volume><issue>1</issue><fpage>17</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2011-0345OC</pub-id><pub-id pub-id-type="other">2-s2.0-84871856593</pub-id><pub-id pub-id-type="pmid">23002098</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlahos</surname><given-names>R.</given-names></name><name><surname>Stambas</surname><given-names>J.</given-names></name><name><surname>Bozinovski</surname><given-names>S.</given-names></name><name><surname>Broughton</surname><given-names>B. R. S.</given-names></name><name><surname>Drummond</surname><given-names>G. R.</given-names></name><name><surname>Selemidis</surname><given-names>S.</given-names></name></person-group><article-title>Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2011</year><volume>7</volume><issue>2, article e1001271</issue><pub-id pub-id-type="doi">10.1371/journal.ppat.1001271</pub-id><pub-id pub-id-type="other">2-s2.0-79952213095</pub-id><?supplied-pmid 21304882?><pub-id pub-id-type="pmid">21304882</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>G. D.</given-names></name><name><surname>Hamers</surname><given-names>A. A. J.</given-names></name><name><surname>Nakao</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Human blood monocyte subsets: a new gating strategy defined using cell surface markers identified by mass cytometry</article-title><source><italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic></source><year>2017</year><volume>37</volume><issue>8</issue><fpage>1548</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.117.309145</pub-id><pub-id pub-id-type="other">2-s2.0-85020685209</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziegler-Heitbrock</surname><given-names>L.</given-names></name></person-group><article-title>Blood monocytes and their subsets: established features and open questions</article-title><source><italic toggle="yes">Frontiers in Immunology</italic></source><year>2015</year><volume>6</volume><fpage>p. 423</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2015.00423</pub-id><pub-id pub-id-type="other">2-s2.0-84941286399</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziegler-Heitbrock</surname><given-names>L.</given-names></name><name><surname>Ancuta</surname><given-names>P.</given-names></name><name><surname>Crowe</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Nomenclature of monocytes and dendritic cells in blood</article-title><source><italic toggle="yes">Blood</italic></source><year>2010</year><volume>116</volume><issue>16</issue><fpage>e74</fpage><lpage>e80</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-02-258558</pub-id><pub-id pub-id-type="other">2-s2.0-77958185103</pub-id><pub-id pub-id-type="pmid">20628149</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baharom</surname><given-names>F.</given-names></name><name><surname>Thomas</surname><given-names>S.</given-names></name><name><surname>Rankin</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Dendritic cells and monocytes with distinct inflammatory responses reside in lung mucosa of healthy humans</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2016</year><volume>196</volume><issue>11</issue><fpage>4498</fpage><lpage>4509</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600071</pub-id><pub-id pub-id-type="other">2-s2.0-84975105655</pub-id><?supplied-pmid 27183618?><pub-id pub-id-type="pmid">27183618</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>G.</given-names></name><name><surname>Haniffa</surname><given-names>M.</given-names></name></person-group><article-title>Human and mouse mononuclear phagocyte networks: a tale of two species?</article-title><source><italic toggle="yes">Frontiers in Immunology</italic></source><year>2015</year><volume>6</volume><fpage>p. 330</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2015.00330</pub-id><pub-id pub-id-type="other">2-s2.0-84935119898</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>X. F.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name></person-group><article-title>Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases</article-title><source><italic toggle="yes">Biomarker Research</italic></source><year>2014</year><volume>2</volume><issue>1</issue><fpage>p. 1</fpage><pub-id pub-id-type="doi">10.1186/2050-7771-2-1</pub-id><pub-id pub-id-type="other">2-s2.0-85040657852</pub-id><?supplied-pmid 24398220?><pub-id pub-id-type="pmid">24398220</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herold</surname><given-names>S.</given-names></name><name><surname>von Wulffen</surname><given-names>W.</given-names></name><name><surname>Steinmueller</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2006</year><volume>177</volume><issue>3</issue><fpage>1817</fpage><lpage>1824</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.3.1817</pub-id><pub-id pub-id-type="other">2-s2.0-33746190787</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bu&#x000df;feld</surname><given-names>D.</given-names></name><name><surname>Kaufmann</surname><given-names>A.</given-names></name><name><surname>Meyer</surname><given-names>R. G.</given-names></name><name><surname>Gemsa</surname><given-names>D.</given-names></name><name><surname>Sprenger</surname><given-names>H.</given-names></name></person-group><article-title>Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus</article-title><source><italic toggle="yes">Cellular Immunology</italic></source><year>1998</year><volume>186</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1006/cimm.1998.1295</pub-id><pub-id pub-id-type="other">2-s2.0-0344765474</pub-id><pub-id pub-id-type="pmid">9637759</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sprenger</surname><given-names>H.</given-names></name><name><surname>Meyer</surname><given-names>R. G.</given-names></name><name><surname>Kaufmann</surname><given-names>A.</given-names></name><name><surname>Bussfeld</surname><given-names>D.</given-names></name><name><surname>Rischkowsky</surname><given-names>E.</given-names></name><name><surname>Gemsa</surname><given-names>D.</given-names></name></person-group><article-title>Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection</article-title><source><italic toggle="yes">Journal of Experimental Medicine</italic></source><year>1996</year><volume>184</volume><issue>3</issue><fpage>1191</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1084/jem.184.3.1191</pub-id><pub-id pub-id-type="other">2-s2.0-0029831336</pub-id><pub-id pub-id-type="pmid">9064338</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zen</surname><given-names>K.</given-names></name><name><surname>Parkos</surname><given-names>C. A.</given-names></name></person-group><article-title>Leukocyte-epithelial interactions</article-title><source><italic toggle="yes">Current Opinion in Cell Biology</italic></source><year>2003</year><volume>15</volume><issue>5</issue><fpage>557</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1016/S0955-0674(03)00103-0</pub-id><pub-id pub-id-type="other">2-s2.0-0141644210</pub-id><pub-id pub-id-type="pmid">14519390</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwiatkowski</surname><given-names>R.</given-names></name><name><surname>Artrip</surname><given-names>J. H.</given-names></name><name><surname>Ankersmit</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Importance of CD49d-VCAM interactions in human monocyte adhesion to porcine endothelium</article-title><source><italic toggle="yes">Xenotransplantation</italic></source><year>1998</year><volume>5</volume><issue>1</issue><fpage>67</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1111/j.1399-3089.1998.tb00011.x</pub-id><pub-id pub-id-type="other">2-s2.0-0031883866</pub-id><pub-id pub-id-type="pmid">9507736</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X. C.</given-names></name><name><surname>Miyasaka</surname><given-names>M.</given-names></name><name><surname>Issekutz</surname><given-names>T. B.</given-names></name></person-group><article-title>Blood monocyte migration to acute lung inflammation involves both CD11/CD18 and very late activation antigen-4-dependent and independent pathways</article-title><source><italic toggle="yes">The Journal of Immunology</italic></source><year>1998</year><volume>161</volume><issue>11</issue><fpage>6258</fpage><lpage>6264</lpage><pub-id pub-id-type="pmid">9834114</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meerschaert</surname><given-names>J.</given-names></name><name><surname>Furie</surname><given-names>M. B.</given-names></name></person-group><article-title>The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium</article-title><source><italic toggle="yes">The Journal of Immunology</italic></source><year>1995</year><volume>154</volume><issue>8</issue><fpage>4099</fpage><lpage>4112</lpage><?supplied-pmid 7535821?><pub-id pub-id-type="pmid">7535821</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosseau</surname><given-names>S.</given-names></name><name><surname>Selhorst</surname><given-names>J.</given-names></name><name><surname>Wiechmann</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Monocyte migration through the alveolar epithelial barrier: adhesion molecule mechanisms and impact of chemokines</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2000</year><volume>164</volume><issue>1</issue><fpage>427</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.164.1.427</pub-id><pub-id pub-id-type="other">2-s2.0-0033957427</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>E. J.</given-names></name><name><surname>Frazier</surname><given-names>W. A.</given-names></name></person-group><article-title>Integrin-associated protein (CD47) and its ligands</article-title><source><italic toggle="yes">Trends in Cell Biology</italic></source><year>2001</year><volume>11</volume><issue>3</issue><fpage>130</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/S0962-8924(00)01906-1</pub-id><pub-id pub-id-type="other">2-s2.0-0035280238</pub-id><?supplied-pmid 11306274?><pub-id pub-id-type="pmid">11306274</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodfin</surname><given-names>A.</given-names></name><name><surname>Voisin</surname><given-names>M. B.</given-names></name><name><surname>Beyrau</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2011</year><volume>12</volume><issue>8</issue><fpage>761</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1038/ni.2062</pub-id><pub-id pub-id-type="other">2-s2.0-80052026271</pub-id><?supplied-pmid 21706006?><pub-id pub-id-type="pmid">21706006</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamichhane</surname><given-names>P. P.</given-names></name><name><surname>Puthavathana</surname><given-names>P.</given-names></name></person-group><article-title>PR8 virus harbouring H5N1 NS gene contributed for THP-1 cell tropism</article-title><source><italic toggle="yes">Virus</italic></source><year>2018</year><volume>29</volume><issue>4</issue><fpage>548</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1007/s13337-018-0499-4</pub-id><pub-id pub-id-type="other">2-s2.0-85055709573</pub-id><?supplied-pmid 30539061?><pub-id pub-id-type="pmid">30539061</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamichhane</surname><given-names>P. P.</given-names></name><name><surname>Boonnak</surname><given-names>K.</given-names></name><name><surname>Changsom</surname><given-names>D.</given-names></name><etal/></person-group><article-title>H5N1 NS genomic segment distinctly governs the influenza virus infectivity and cytokine induction in monocytic cells</article-title><source><italic toggle="yes">Asian Pacific Journal of Allergy and Immunology</italic></source><year>2018</year><volume>36</volume><issue>1</issue><fpage>58</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">28802028</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>A. C. Y.</given-names></name><name><surname>To</surname><given-names>K. K. W.</given-names></name><name><surname>Zhu</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Avian influenza virus A H7N9 infects multiple mononuclear cell types in peripheral blood and induces dysregulated cytokine responses and apoptosis in infected monocytes</article-title><source><italic toggle="yes">The Journal of General Virology</italic></source><year>2017</year><volume>98</volume><issue>5</issue><fpage>922</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1099/jgv.0.000751</pub-id><pub-id pub-id-type="other">2-s2.0-85020474547</pub-id><?supplied-pmid 28555541?><pub-id pub-id-type="pmid">28555541</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vongsakul</surname><given-names>M.</given-names></name><name><surname>Kasisith</surname><given-names>J.</given-names></name><name><surname>Noisumdaeng</surname><given-names>P.</given-names></name><name><surname>Puthavathana</surname><given-names>P.</given-names></name></person-group><article-title>The difference in IL-1<italic>&#x003b2;</italic>, MIP-1<italic>&#x003b1;</italic>, IL-8 and IL-18 production between the infection of PMA activated U937 cells with recombinant vaccinia viruses inserted 2004 H5N1 influenza HA genes and NS genes</article-title><source><italic toggle="yes">Asian Pacific Journal of Allergy and Immunology</italic></source><year>2011</year><volume>29</volume><issue>4</issue><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">22299315</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>S.</given-names></name><name><surname>Ehrhardt</surname><given-names>C.</given-names></name><name><surname>Neumeier</surname><given-names>E. R.</given-names></name><name><surname>Kracht</surname><given-names>M.</given-names></name><name><surname>Rapp</surname><given-names>U. R.</given-names></name><name><surname>Pleschka</surname><given-names>S.</given-names></name></person-group><article-title>Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway</article-title><source><italic toggle="yes">The Journal of Biological Chemistry</italic></source><year>2001</year><volume>276</volume><issue>14</issue><fpage>10990</fpage><lpage>10998</lpage><pub-id pub-id-type="doi">10.1074/jbc.M009902200</pub-id><pub-id pub-id-type="other">2-s2.0-0035815684</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palipane</surname><given-names>M.</given-names></name><name><surname>Snyder</surname><given-names>J. D.</given-names></name><name><surname>LeMessurier</surname><given-names>K. S.</given-names></name><name><surname>Schofield</surname><given-names>A. K.</given-names></name><name><surname>Woolard</surname><given-names>S. N.</given-names></name><name><surname>Samarasinghe</surname><given-names>A. E.</given-names></name></person-group><article-title>Macrophage CD14 impacts immune defenses against influenza virus in allergic hosts</article-title><source><italic toggle="yes">Microbial Pathogenesis</italic></source><year>2019</year><volume>127</volume><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.12.008</pub-id><pub-id pub-id-type="other">2-s2.0-85058033711</pub-id><pub-id pub-id-type="pmid">30529429</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cline</surname><given-names>T. D.</given-names></name><name><surname>Beck</surname><given-names>D.</given-names></name><name><surname>Bianchini</surname><given-names>E.</given-names></name></person-group><article-title>Influenza virus replication in macrophages: balancing protection and pathogenesis</article-title><source><italic toggle="yes">The Journal of General Virology</italic></source><year>2017</year><volume>98</volume><issue>10</issue><fpage>2401</fpage><lpage>2412</lpage><pub-id pub-id-type="doi">10.1099/jgv.0.000922</pub-id><pub-id pub-id-type="other">2-s2.0-85030986521</pub-id><pub-id pub-id-type="pmid">28884667</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicol</surname><given-names>M. Q.</given-names></name><name><surname>Dutia</surname><given-names>B. M.</given-names></name></person-group><article-title>The role of macrophages in influenza A virus infection</article-title><source><italic toggle="yes">Future Virology</italic></source><year>2014</year><volume>9</volume><issue>9</issue><fpage>847</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.2217/fvl.14.65</pub-id><pub-id pub-id-type="other">2-s2.0-84908248922</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S. J.</given-names></name><name><surname>Lo</surname><given-names>M.</given-names></name><name><surname>Kuo</surname><given-names>R. L.</given-names></name><etal/></person-group><article-title>The pathological effects of CCR2+ inflammatory monocytes are amplified by an IFNAR1-triggered chemokine feedback loop in highly pathogenic influenza infection</article-title><source><italic toggle="yes">Journal of Biomedical Science</italic></source><year>2014</year><volume>21</volume><issue>1</issue><fpage>p. 99</fpage><pub-id pub-id-type="doi">10.1186/s12929-014-0099-6</pub-id><pub-id pub-id-type="other">2-s2.0-84964312851</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>K. L.</given-names></name><name><surname>Suzuki</surname><given-names>Y.</given-names></name><name><surname>Nakano</surname><given-names>H.</given-names></name><name><surname>Ramsburg</surname><given-names>E.</given-names></name><name><surname>Gunn</surname><given-names>M. D.</given-names></name></person-group><article-title>CCR2<sup>+</sup> monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality</article-title><source><italic toggle="yes">The Journal of Immunology</italic></source><year>2008</year><volume>180</volume><issue>4</issue><fpage>2562</fpage><lpage>2572</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.4.2562</pub-id><pub-id pub-id-type="other">2-s2.0-42149083307</pub-id><pub-id pub-id-type="pmid">18250467</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>T. C.</given-names></name><name><surname>Beck</surname><given-names>M. A.</given-names></name><name><surname>Kuziel</surname><given-names>W. A.</given-names></name><name><surname>Henderson</surname><given-names>F.</given-names></name><name><surname>Maeda</surname><given-names>N.</given-names></name></person-group><article-title>Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus</article-title><source><italic toggle="yes">The American Journal of Pathology</italic></source><year>2000</year><volume>156</volume><issue>6</issue><fpage>1951</fpage><lpage>1959</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)65068-7</pub-id><pub-id pub-id-type="other">2-s2.0-0033872286</pub-id><pub-id pub-id-type="pmid">10854218</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaynagetdinov</surname><given-names>R.</given-names></name><name><surname>Sherrill</surname><given-names>T. P.</given-names></name><name><surname>Kendall</surname><given-names>P. L.</given-names></name><etal/></person-group><article-title>Identification of myeloid cell subsets in murine lungs using flow cytometry</article-title><source><italic toggle="yes">American Journal of Respiratory Cell and Molecular Biology</italic></source><year>2013</year><volume>49</volume><issue>2</issue><fpage>180</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2012-0366MA</pub-id><pub-id pub-id-type="other">2-s2.0-84881492566</pub-id><pub-id pub-id-type="pmid">23492192</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liegeois</surname><given-names>M.</given-names></name><name><surname>Legrand</surname><given-names>C.</given-names></name><name><surname>Desmet</surname><given-names>C. J.</given-names></name><name><surname>Marichal</surname><given-names>T.</given-names></name><name><surname>Bureau</surname><given-names>F.</given-names></name></person-group><article-title>The interstitial macrophage: a long-neglected piece in the puzzle of lung immunity</article-title><source><italic toggle="yes">Cellular Immunology</italic></source><year>2018</year><volume>330</volume><fpage>91</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2018.02.001</pub-id><pub-id pub-id-type="other">2-s2.0-85042094210</pub-id><pub-id pub-id-type="pmid">29458975</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fathi</surname><given-names>M.</given-names></name><name><surname>Johansson</surname><given-names>A.</given-names></name><name><surname>Lundborg</surname><given-names>M.</given-names></name><name><surname>Orre</surname><given-names>L.</given-names></name><name><surname>Sk&#x000f6;ld</surname><given-names>C. M.</given-names></name><name><surname>Camner</surname><given-names>P.</given-names></name></person-group><article-title>Functional and morphological differences between human alveolar and interstitial macrophages</article-title><source><italic toggle="yes">Experimental and Molecular Pathology</italic></source><year>2001</year><volume>70</volume><issue>2</issue><fpage>77</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1006/exmp.2000.2344</pub-id><pub-id pub-id-type="other">2-s2.0-0035571702</pub-id><pub-id pub-id-type="pmid">11263950</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopf</surname><given-names>M.</given-names></name><name><surname>Schneider</surname><given-names>C.</given-names></name><name><surname>Nobs</surname><given-names>S. P.</given-names></name></person-group><article-title>The development and function of lung-resident macrophages and dendritic cells</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2015</year><volume>16</volume><issue>1</issue><fpage>36</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1038/ni.3052</pub-id><pub-id pub-id-type="other">2-s2.0-84925283050</pub-id><pub-id pub-id-type="pmid">25521683</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussell</surname><given-names>T.</given-names></name><name><surname>Bell</surname><given-names>T. J.</given-names></name></person-group><article-title>Alveolar macrophages: plasticity in a tissue-specific context</article-title><source><italic toggle="yes">Nature Reviews Immunology</italic></source><year>2014</year><volume>14</volume><issue>2</issue><fpage>81</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/nri3600</pub-id><pub-id pub-id-type="other">2-s2.0-84893652705</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Buttgereit</surname><given-names>A.</given-names></name><name><surname>Lelios</surname><given-names>I.</given-names></name><etal/></person-group><article-title>The cytokine TGF-<italic>&#x003b2;</italic> promotes the development and homeostasis of alveolar macrophages</article-title><source><italic toggle="yes">Immunity</italic></source><year>2017</year><volume>47</volume><issue>5</issue><fpage>903</fpage><lpage>912.e4</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.10.007</pub-id><pub-id pub-id-type="other">2-s2.0-85032904932</pub-id><pub-id pub-id-type="pmid">29126797</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Laar</surname><given-names>L.</given-names></name><name><surname>Saelens</surname><given-names>W.</given-names></name><name><surname>de Prijck</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Yolk sac macrophages, fetal liver, and adult monocytes can colonize an empty niche and develop into functional tissue-resident macrophages</article-title><source><italic toggle="yes">Immunity</italic></source><year>2016</year><volume>44</volume><issue>4</issue><fpage>755</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.017</pub-id><pub-id pub-id-type="other">2-s2.0-84960920909</pub-id><pub-id pub-id-type="pmid">26992565</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M.</given-names></name><name><surname>de Kleer</surname><given-names>I.</given-names></name><name><surname>Henri</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF</article-title><source><italic toggle="yes">Journal of Experimental Medicine</italic></source><year>2013</year><volume>210</volume><issue>10</issue><fpage>1977</fpage><lpage>1992</lpage><pub-id pub-id-type="doi">10.1084/jem.20131199</pub-id><pub-id pub-id-type="other">2-s2.0-84885454468</pub-id><pub-id pub-id-type="pmid">24043763</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez Perdiguero</surname><given-names>E.</given-names></name><name><surname>Klapproth</surname><given-names>K.</given-names></name><name><surname>Schulz</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors</article-title><source><italic toggle="yes">Nature</italic></source><year>2015</year><volume>518</volume><issue>7540</issue><fpage>547</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1038/nature13989</pub-id><pub-id pub-id-type="other">2-s2.0-84925465211</pub-id><?supplied-pmid 25470051?><pub-id pub-id-type="pmid">25470051</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarling</surname><given-names>J. D.</given-names></name><name><surname>Lin</surname><given-names>H. S.</given-names></name><name><surname>Hsu</surname><given-names>S.</given-names></name></person-group><article-title>Self-renewal of pulmonary alveolar macrophages: evidence from radiation chimera studies</article-title><source><italic toggle="yes">Journal of Leukocyte Biology</italic></source><year>1987</year><volume>42</volume><issue>5</issue><fpage>443</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1002/jlb.42.5.443</pub-id><pub-id pub-id-type="other">2-s2.0-0023638337</pub-id><pub-id pub-id-type="pmid">3316460</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawyer</surname><given-names>R. T.</given-names></name></person-group><article-title>The cytokinetic behavior of pulmonary alveolar macrophages in monocytopenic mice</article-title><source><italic toggle="yes">Journal of Leukocyte Biology</italic></source><year>1986</year><volume>39</volume><issue>1</issue><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1002/jlb.39.1.89</pub-id><pub-id pub-id-type="pmid">3455713</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snelgrove</surname><given-names>R. J.</given-names></name><name><surname>Goulding</surname><given-names>J.</given-names></name><name><surname>Didierlaurent</surname><given-names>A. M.</given-names></name><etal/></person-group><article-title>A critical function for CD200 in lung immune homeostasis and the severity of influenza infection</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2008</year><volume>9</volume><issue>9</issue><fpage>1074</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1038/ni.1637</pub-id><pub-id pub-id-type="other">2-s2.0-50049100345</pub-id><pub-id pub-id-type="pmid">18660812</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. M.</given-names></name><name><surname>Lee</surname><given-names>Y. W.</given-names></name><name><surname>Lee</surname><given-names>K. J.</given-names></name><etal/></person-group><article-title>Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2008</year><volume>82</volume><issue>9</issue><fpage>4265</fpage><lpage>4274</lpage><pub-id pub-id-type="doi">10.1128/JVI.02602-07</pub-id><pub-id pub-id-type="other">2-s2.0-42449095509</pub-id><pub-id pub-id-type="pmid">18287245</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>M. D.</given-names></name><name><surname>Pickett</surname><given-names>D. L.</given-names></name><name><surname>van Rooijen</surname><given-names>N.</given-names></name><name><surname>Brooks</surname><given-names>A. G.</given-names></name><name><surname>Reading</surname><given-names>P. C.</given-names></name></person-group><article-title>Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2010</year><volume>84</volume><issue>15</issue><fpage>7569</fpage><lpage>7580</lpage><pub-id pub-id-type="doi">10.1128/JVI.00291-10</pub-id><pub-id pub-id-type="other">2-s2.0-77954492854</pub-id><?supplied-pmid 20504924?><pub-id pub-id-type="pmid">20504924</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardani</surname><given-names>A.</given-names></name><name><surname>Boulton</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>T. S.</given-names></name><name><surname>Braciale</surname><given-names>T. J.</given-names></name></person-group><article-title>Alveolar macrophages prevent lethal influenza pneumonia by inhibiting infection of type-1 alveolar epithelial cells</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2017</year><volume>13</volume><issue>1, article e1006140</issue><pub-id pub-id-type="doi">10.1371/journal.ppat.1006140</pub-id><pub-id pub-id-type="other">2-s2.0-85010977567</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>C.</given-names></name><name><surname>Nobs</surname><given-names>S. P.</given-names></name><name><surname>Heer</surname><given-names>A. K.</given-names></name><etal/></person-group><article-title>Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2014</year><volume>10</volume><issue>4, article e1004053</issue><pub-id pub-id-type="doi">10.1371/journal.ppat.1004053</pub-id><pub-id pub-id-type="other">2-s2.0-84901379724</pub-id><?supplied-pmid 24699679?><pub-id pub-id-type="pmid">24699679</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Nikrad</surname><given-names>M. P.</given-names></name><name><surname>Travanty</surname><given-names>E. A.</given-names></name><etal/></person-group><article-title>Innate immune response of human alveolar macrophages during influenza A infection</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2012</year><volume>7</volume><issue>3, article e29879</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0029879</pub-id><pub-id pub-id-type="other">2-s2.0-84863290608</pub-id><?supplied-pmid 22396727?><pub-id pub-id-type="pmid">22396727</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W. C. L.</given-names></name><name><surname>Chan</surname><given-names>R. W. Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2011</year><volume>85</volume><issue>14</issue><fpage>6844</fpage><lpage>6855</lpage><pub-id pub-id-type="doi">10.1128/JVI.02200-10</pub-id><pub-id pub-id-type="other">2-s2.0-79960418204</pub-id><?supplied-pmid 21543489?><pub-id pub-id-type="pmid">21543489</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ettensohn</surname><given-names>D. B.</given-names></name><name><surname>Frampton</surname><given-names>M. W.</given-names></name><name><surname>Nichols</surname><given-names>J. E.</given-names></name><name><surname>Roberts</surname><given-names>N. J.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Human alveolar macrophages may not be susceptible to direct infection by a human influenza virus</article-title><source><italic toggle="yes">The Journal of Infectious Diseases</italic></source><year>2016</year><volume>214</volume><issue>11</issue><fpage>1658</fpage><lpage>1665</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw413</pub-id><pub-id pub-id-type="other">2-s2.0-85014693234</pub-id><pub-id pub-id-type="pmid">27601618</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Londrigan</surname><given-names>S. L.</given-names></name><name><surname>Short</surname><given-names>K. R.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Infection of mouse macrophages by seasonal influenza viruses can be restricted at the level of virus entry and at a late stage in the virus life cycle</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2015</year><volume>89</volume><issue>24</issue><fpage>12319</fpage><lpage>12329</lpage><pub-id pub-id-type="doi">10.1128/JVI.01455-15</pub-id><pub-id pub-id-type="other">2-s2.0-84949755414</pub-id><pub-id pub-id-type="pmid">26423941</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G.</given-names></name></person-group><article-title>Type I interferon: friend or foe?</article-title><source><italic toggle="yes">Journal of Experimental Medicine</italic></source><year>2010</year><volume>207</volume><issue>10</issue><fpage>2053</fpage><lpage>2063</lpage><pub-id pub-id-type="doi">10.1084/jem.20101664</pub-id><pub-id pub-id-type="other">2-s2.0-77957745555</pub-id><pub-id pub-id-type="pmid">20837696</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>H. E.</given-names></name><name><surname>Nicholas</surname><given-names>T. E.</given-names></name></person-group><article-title>Alveolar type I and type II cells</article-title><source><italic toggle="yes">Australian and New Zealand Journal of Medicine</italic></source><year>1984</year><volume>14</volume><issue>5, Supplement 3</issue><fpage>731</fpage><lpage>734</lpage><pub-id pub-id-type="doi">10.1111/j.1445-5994.1984.tb04928.x</pub-id><pub-id pub-id-type="other">2-s2.0-0021675427</pub-id><pub-id pub-id-type="pmid">6598039</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>C.</given-names></name><name><surname>Nobs</surname><given-names>S. P.</given-names></name><name><surname>Kurrer</surname><given-names>M.</given-names></name><name><surname>Rehrauer</surname><given-names>H.</given-names></name><name><surname>Thiele</surname><given-names>C.</given-names></name><name><surname>Kopf</surname><given-names>M.</given-names></name></person-group><article-title>Induction of the nuclear receptor PPAR-<italic>&#x003b3;</italic> by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2014</year><volume>15</volume><issue>11</issue><fpage>1026</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1038/ni.3005</pub-id><pub-id pub-id-type="other">2-s2.0-84908148912</pub-id><?supplied-pmid 25263125?><pub-id pub-id-type="pmid">25263125</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname><given-names>A.</given-names></name></person-group><article-title>Control of macrophage activation and function by PPARs</article-title><source><italic toggle="yes">Circulation Research</italic></source><year>2010</year><volume>106</volume><issue>10</issue><fpage>1559</fpage><lpage>1569</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.216523</pub-id><pub-id pub-id-type="other">2-s2.0-77952997178</pub-id><?supplied-pmid 20508200?><pub-id pub-id-type="pmid">20508200</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moseley</surname><given-names>C. E.</given-names></name><name><surname>Webster</surname><given-names>R. G.</given-names></name><name><surname>Aldridge</surname><given-names>J. R.</given-names></name></person-group><article-title>Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice</article-title><source><italic toggle="yes">Influenza and Other Respiratory Viruses</italic></source><year>2010</year><volume>4</volume><issue>5</issue><fpage>307</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.1111/j.1750-2659.2010.00155.x</pub-id><pub-id pub-id-type="other">2-s2.0-77955796417</pub-id><?supplied-pmid 20716159?><pub-id pub-id-type="pmid">20716159</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>B.</given-names></name><name><surname>Cheon</surname><given-names>I. S.</given-names></name><etal/></person-group><article-title>PPAR-<italic>&#x003b3;</italic> in macrophages limits pulmonary inflammation and promotes host recovery following respiratory viral infection</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2019</year><volume>93</volume><issue>9</issue><pub-id pub-id-type="doi">10.1128/JVI.00030-19</pub-id><?supplied-pmid 30787149?><pub-id pub-id-type="pmid">30787149</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Law</surname><given-names>H. K. W.</given-names></name><name><surname>Cheung</surname><given-names>C. Y.</given-names></name><name><surname>Ng</surname><given-names>I. H. Y.</given-names></name><name><surname>Peiris</surname><given-names>J. S. M.</given-names></name><name><surname>Lau</surname><given-names>Y. L.</given-names></name></person-group><article-title>Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses</article-title><source><italic toggle="yes">The Journal of Infectious Diseases</italic></source><year>2006</year><volume>194</volume><issue>1</issue><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1086/504690</pub-id><pub-id pub-id-type="other">2-s2.0-33745216720</pub-id><?supplied-pmid 16741883?><pub-id pub-id-type="pmid">16741883</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>C. Y.</given-names></name><name><surname>Poon</surname><given-names>L. L. M.</given-names></name><name><surname>Lau</surname><given-names>A. S.</given-names></name><etal/></person-group><article-title>Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?</article-title><source><italic toggle="yes">The Lancet</italic></source><year>2002</year><volume>360</volume><issue>9348</issue><fpage>1831</fpage><lpage>1837</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(02)11772-7</pub-id><pub-id pub-id-type="other">2-s2.0-0037038866</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friesenhagen</surname><given-names>J.</given-names></name><name><surname>Boergeling</surname><given-names>Y.</given-names></name><name><surname>Hrincius</surname><given-names>E.</given-names></name><name><surname>Ludwig</surname><given-names>S.</given-names></name><name><surname>Roth</surname><given-names>J.</given-names></name><name><surname>Viemann</surname><given-names>D.</given-names></name></person-group><article-title>Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophages</article-title><source><italic toggle="yes">Journal of Leukocyte Biology</italic></source><year>2012</year><volume>92</volume><issue>1</issue><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1189/jlb.0911479</pub-id><pub-id pub-id-type="other">2-s2.0-84863444137</pub-id><pub-id pub-id-type="pmid">22442495</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waithman</surname><given-names>J.</given-names></name><name><surname>Mintern</surname><given-names>J. D.</given-names></name></person-group><article-title>Dendritic cells and influenza A virus infection</article-title><source><italic toggle="yes">Virulence</italic></source><year>2012</year><volume>3</volume><issue>7</issue><fpage>603</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.4161/viru.21864</pub-id><pub-id pub-id-type="other">2-s2.0-84870953470</pub-id><?supplied-pmid 23076333?><pub-id pub-id-type="pmid">23076333</pub-id></element-citation></ref><ref id="B120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>W. R.</given-names></name><name><surname>Carbone</surname><given-names>F. R.</given-names></name></person-group><article-title>Dendritic cell subsets in primary and secondary T cell responses at body surfaces</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2009</year><volume>10</volume><issue>12</issue><fpage>1237</fpage><lpage>1244</lpage><pub-id pub-id-type="doi">10.1038/ni.1822</pub-id><pub-id pub-id-type="other">2-s2.0-70449732252</pub-id><pub-id pub-id-type="pmid">19915624</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shortman</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>Y. J.</given-names></name></person-group><article-title>Mouse and human dendritic cell subtypes</article-title><source><italic toggle="yes">Nature Reviews Immunology</italic></source><year>2002</year><volume>2</volume><issue>3</issue><fpage>151</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1038/nri746</pub-id><pub-id pub-id-type="other">2-s2.0-0036518287</pub-id></element-citation></ref><ref id="B122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y. J.</given-names></name><name><surname>Kanzler</surname><given-names>H.</given-names></name><name><surname>Soumelis</surname><given-names>V.</given-names></name><name><surname>Gilliet</surname><given-names>M.</given-names></name></person-group><article-title>Dendritic cell lineage, plasticity and cross-regulation</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2001</year><volume>2</volume><issue>7</issue><fpage>585</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/89726</pub-id><pub-id pub-id-type="other">2-s2.0-0034919938</pub-id><pub-id pub-id-type="pmid">11429541</pub-id></element-citation></ref><ref id="B123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>S.-S. J.</given-names></name><name><surname>Fu</surname><given-names>S. M.</given-names></name><name><surname>Rose</surname><given-names>C. E.</given-names><suffix>Jr.</suffix></name><name><surname>Gaskin</surname><given-names>F.</given-names></name><name><surname>Ju</surname><given-names>S. T.</given-names></name><name><surname>Beaty</surname><given-names>S. R.</given-names></name></person-group><article-title>A major lung CD103 (<italic>&#x003b1;</italic><sub>E</sub>)-<italic>&#x003b2;</italic><sub>7</sub> integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins</article-title><source><italic toggle="yes">The Journal of Immunology</italic></source><year>2006</year><volume>176</volume><issue>4</issue><fpage>2161</fpage><lpage>2172</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.176.4.2161</pub-id><pub-id pub-id-type="pmid">16455972</pub-id></element-citation></ref><ref id="B124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambrecht</surname><given-names>B. N.</given-names></name><name><surname>Hammad</surname><given-names>H.</given-names></name></person-group><article-title>Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology</article-title><source><italic toggle="yes">Annual Review of Immunology</italic></source><year>2012</year><volume>30</volume><issue>1</issue><fpage>243</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075021</pub-id><pub-id pub-id-type="other">2-s2.0-84859404292</pub-id></element-citation></ref><ref id="B125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaty</surname><given-names>S. R.</given-names></name><name><surname>Rose</surname><given-names>C. E.</given-names><suffix>Jr.</suffix></name><name><surname>Sung</surname><given-names>S. S. J.</given-names></name></person-group><article-title>Diverse and potent chemokine production by lung CD11b<sup>high</sup> dendritic cells in homeostasis and in allergic lung inflammation</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2007</year><volume>178</volume><issue>3</issue><fpage>1882</fpage><lpage>1895</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.3.1882</pub-id><pub-id pub-id-type="other">2-s2.0-33846490362</pub-id><?supplied-pmid 17237439?><pub-id pub-id-type="pmid">17237439</pub-id></element-citation></ref><ref id="B126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helft</surname><given-names>J.</given-names></name><name><surname>Ginhoux</surname><given-names>F.</given-names></name><name><surname>Bogunovic</surname><given-names>M.</given-names></name><name><surname>Merad</surname><given-names>M.</given-names></name></person-group><article-title>Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice</article-title><source><italic toggle="yes">Immunological Reviews</italic></source><year>2010</year><volume>234</volume><issue>1</issue><fpage>55</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1111/j.0105-2896.2009.00885.x</pub-id><pub-id pub-id-type="other">2-s2.0-77349095894</pub-id><pub-id pub-id-type="pmid">20193012</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>GeurtsvanKessel</surname><given-names>C. H.</given-names></name><name><surname>Willart</surname><given-names>M. A. M.</given-names></name><name><surname>van Rijt</surname><given-names>L. S.</given-names></name><etal/></person-group><article-title>Clearance of influenza virus from the lung depends on migratory langerin<sup>+</sup>CD11b<sup>&#x02212;</sup> but not plasmacytoid dendritic cells</article-title><source><italic toggle="yes">Journal of Experimental Medicine</italic></source><year>2008</year><volume>205</volume><issue>7</issue><fpage>1621</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.1084/jem.20071365</pub-id><pub-id pub-id-type="other">2-s2.0-46949109891</pub-id><?supplied-pmid 18591406?><pub-id pub-id-type="pmid">18591406</pub-id></element-citation></ref><ref id="B128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtner</surname><given-names>M.</given-names></name><name><surname>Mastroianni</surname><given-names>C. M.</given-names></name><name><surname>Rossi</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2011</year><volume>6</volume><issue>5, article e19872</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0019872</pub-id><pub-id pub-id-type="other">2-s2.0-79956262500</pub-id><?supplied-pmid 21625541?><pub-id pub-id-type="pmid">21625541</pub-id></element-citation></ref><ref id="B129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>M. A.</given-names></name><name><surname>Long</surname><given-names>K.</given-names></name><name><surname>Kwon</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection</article-title><source><italic toggle="yes">The Journal of Infectious Diseases</italic></source><year>2008</year><volume>198</volume><issue>11</issue><fpage>1667</fpage><lpage>1676</lpage><pub-id pub-id-type="doi">10.1086/593018</pub-id><pub-id pub-id-type="other">2-s2.0-56649097473</pub-id><?supplied-pmid 18847373?><pub-id pub-id-type="pmid">18847373</pub-id></element-citation></ref><ref id="B130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>M. A.</given-names></name><name><surname>Palucka</surname><given-names>A. K.</given-names></name><name><surname>Barton</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections</article-title><source><italic toggle="yes">The Journal of Infectious Diseases</italic></source><year>2005</year><volume>191</volume><issue>7</issue><fpage>1105</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1086/428589</pub-id><pub-id pub-id-type="other">2-s2.0-15544362414</pub-id><?supplied-pmid 15747246?><pub-id pub-id-type="pmid">15747246</pub-id></element-citation></ref><ref id="B131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>A. W. S.</given-names></name><name><surname>Prabhu</surname><given-names>N.</given-names></name><name><surname>Betts</surname><given-names>R. J.</given-names></name><etal/></person-group><article-title>Lung CD103<sup>+</sup> dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells</article-title><source><italic toggle="yes">The Journal of Immunology</italic></source><year>2011</year><volume>187</volume><issue>11</issue><fpage>6011</fpage><lpage>6021</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100987</pub-id><pub-id pub-id-type="other">2-s2.0-82755189241</pub-id><?supplied-pmid 22043017?><pub-id pub-id-type="pmid">22043017</pub-id></element-citation></ref><ref id="B132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helft</surname><given-names>J.</given-names></name><name><surname>Manicassamy</surname><given-names>B.</given-names></name><name><surname>Guermonprez</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Cross-presenting CD103<sup>+</sup> dendritic cells are protected from influenza virus infection</article-title><source><italic toggle="yes">Journal of Clinical Investigation</italic></source><year>2012</year><volume>122</volume><issue>11</issue><fpage>4037</fpage><lpage>4047</lpage><pub-id pub-id-type="doi">10.1172/JCI60659</pub-id><pub-id pub-id-type="other">2-s2.0-84868628564</pub-id><?supplied-pmid 23041628?><pub-id pub-id-type="pmid">23041628</pub-id></element-citation></ref><ref id="B133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>del Rio</surname><given-names>M.-L.</given-names></name><name><surname>Rodriguez-Barbosa</surname><given-names>J. I.</given-names></name><name><surname>Kremmer</surname><given-names>E.</given-names></name><name><surname>F&#x000f6;rster</surname><given-names>R.</given-names></name></person-group><article-title>CD103<sup>&#x02212;</sup> and CD103<sup>+</sup> bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4<sup>+</sup> and CD8<sup>+</sup> T cells</article-title><source><italic toggle="yes">The Journal of Immunology</italic></source><year>2007</year><volume>178</volume><issue>11</issue><fpage>6861</fpage><lpage>6866</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.11.6861</pub-id><pub-id pub-id-type="other">2-s2.0-34249786244</pub-id><pub-id pub-id-type="pmid">17513734</pub-id></element-citation></ref><ref id="B134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moltedo</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Yount</surname><given-names>J. S.</given-names></name><name><surname>Moran</surname><given-names>T. M.</given-names></name></person-group><article-title>Unique type I interferon responses determine the functional fate of migratory lung dendritic cells during influenza virus infection</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2011</year><volume>7</volume><issue>11, article e1002345</issue><pub-id pub-id-type="doi">10.1371/journal.ppat.1002345</pub-id><pub-id pub-id-type="other">2-s2.0-81755187264</pub-id><?supplied-pmid 22072965?><pub-id pub-id-type="pmid">22072965</pub-id></element-citation></ref><ref id="B135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T. S.</given-names></name><name><surname>Braciale</surname><given-names>T. J.</given-names></name></person-group><article-title>Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8<sup>+</sup> T cell responses</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2009</year><volume>4</volume><issue>1, article e4204</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0004204</pub-id><pub-id pub-id-type="other">2-s2.0-58449134844</pub-id><?supplied-pmid 19145246?><pub-id pub-id-type="pmid">19145246</pub-id></element-citation></ref><ref id="B136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikhak</surname><given-names>Z.</given-names></name><name><surname>Strassner</surname><given-names>J. P.</given-names></name><name><surname>Luster</surname><given-names>A. D.</given-names></name></person-group><article-title>Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4</article-title><source><italic toggle="yes">Journal of Experimental Medicine</italic></source><year>2013</year><volume>210</volume><issue>9</issue><fpage>1855</fpage><lpage>1869</lpage><pub-id pub-id-type="doi">10.1084/jem.20130091</pub-id><pub-id pub-id-type="other">2-s2.0-84884265702</pub-id><?supplied-pmid 23960189?><pub-id pub-id-type="pmid">23960189</pub-id></element-citation></ref><ref id="B137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iparraguirre</surname><given-names>A.</given-names></name><name><surname>Tobias</surname><given-names>J. W.</given-names></name><name><surname>Hensley</surname><given-names>S. E.</given-names></name><etal/></person-group><article-title>Two distinct activation states of plasmacytoid dendritic cells induced by influenza virus and CpG 1826 oligonucleotide</article-title><source><italic toggle="yes">Journal of Leukocyte Biology</italic></source><year>2008</year><volume>83</volume><issue>3</issue><fpage>610</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1189/jlb.0807511</pub-id><pub-id pub-id-type="other">2-s2.0-43349102823</pub-id><?supplied-pmid 18029397?><pub-id pub-id-type="pmid">18029397</pub-id></element-citation></ref><ref id="B138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>A. I.</given-names></name><name><surname>Buehler</surname><given-names>D.</given-names></name><name><surname>Hensley</surname><given-names>S. E.</given-names></name><etal/></person-group><article-title>Plasmacytoid dendritic cells are dispensable during primary influenza virus infection</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2009</year><volume>182</volume><issue>2</issue><fpage>871</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.182.2.871</pub-id><pub-id pub-id-type="other">2-s2.0-60549108826</pub-id><?supplied-pmid 19124730?><pub-id pub-id-type="pmid">19124730</pub-id></element-citation></ref><ref id="B139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thitithanyanont</surname><given-names>A.</given-names></name><name><surname>Engering</surname><given-names>A.</given-names></name><name><surname>Ekchariyawat</surname><given-names>P.</given-names></name><etal/></person-group><article-title>High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-<italic>&#x003b1;</italic> and TLR ligands</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2007</year><volume>179</volume><issue>8</issue><fpage>5220</fpage><lpage>5227</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.8.5220</pub-id></element-citation></ref><ref id="B140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vangeti</surname><given-names>S.</given-names></name><name><surname>Gertow</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Human blood and tonsil plasmacytoid dendritic cells display similar gene expression profiles but exhibit differential type I IFN responses to influenza A virus infection</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2019</year><volume>202</volume><issue>7</issue><fpage>2069</fpage><lpage>2081</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1801191</pub-id><pub-id pub-id-type="other">2-s2.0-85063255697</pub-id><?supplied-pmid 30760619?><pub-id pub-id-type="pmid">30760619</pub-id></element-citation></ref><ref id="B141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lui</surname><given-names>G.</given-names></name><name><surname>Manches</surname><given-names>O.</given-names></name><name><surname>Angel</surname><given-names>J.</given-names></name><name><surname>Molens</surname><given-names>J. P.</given-names></name><name><surname>Chaperot</surname><given-names>L.</given-names></name><name><surname>Plumas</surname><given-names>J.</given-names></name></person-group><article-title>Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2009</year><volume>4</volume><issue>9, article e7111</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0007111</pub-id><pub-id pub-id-type="other">2-s2.0-70349579498</pub-id><?supplied-pmid 19771163?><pub-id pub-id-type="pmid">19771163</pub-id></element-citation></ref><ref id="B142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jego</surname><given-names>G.</given-names></name><name><surname>Palucka</surname><given-names>A. K.</given-names></name><name><surname>Blanck</surname><given-names>J. P.</given-names></name><name><surname>Chalouni</surname><given-names>C.</given-names></name><name><surname>Pascual</surname><given-names>V.</given-names></name><name><surname>Banchereau</surname><given-names>J.</given-names></name></person-group><article-title>Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6</article-title><source><italic toggle="yes">Immunity</italic></source><year>2003</year><volume>19</volume><issue>2</issue><fpage>225</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(03)00208-5</pub-id><pub-id pub-id-type="other">2-s2.0-0041429619</pub-id><pub-id pub-id-type="pmid">12932356</pub-id></element-citation></ref><ref id="B143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doorley</surname><given-names>L. A.</given-names></name><name><surname>LeMessurier</surname><given-names>K. S.</given-names></name><name><surname>Iverson</surname><given-names>A. R.</given-names></name><name><surname>Palipane</surname><given-names>M.</given-names></name><name><surname>Samarasinghe</surname><given-names>A. E.</given-names></name></person-group><article-title>Humoral immune responses during asthma and influenza co-morbidity in mice</article-title><source><italic toggle="yes">Immunobiology</italic></source><year>2017</year><volume>222</volume><issue>12</issue><fpage>1064</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1016/j.imbio.2017.08.002</pub-id><pub-id pub-id-type="other">2-s2.0-85031015153</pub-id><pub-id pub-id-type="pmid">28889999</pub-id></element-citation></ref><ref id="B144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandbulte</surname><given-names>M. R.</given-names></name><name><surname>Boon</surname><given-names>A. C. M.</given-names></name><name><surname>Webby</surname><given-names>R. J.</given-names></name><name><surname>Riberdy</surname><given-names>J. M.</given-names></name></person-group><article-title>Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses</article-title><source><italic toggle="yes">Virology</italic></source><year>2008</year><volume>381</volume><issue>1</issue><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2008.08.018</pub-id><pub-id pub-id-type="other">2-s2.0-54049144181</pub-id><?supplied-pmid 18801551?><pub-id pub-id-type="pmid">18801551</pub-id></element-citation></ref><ref id="B145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonteneau</surname><given-names>J.-F.</given-names></name><name><surname>Gilliet</surname><given-names>M.</given-names></name><name><surname>Larsson</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Activation of influenza virus-specific CD4<sup>+</sup> and CD8<sup>+</sup> T cells: a new role for plasmacytoid dendritic cells in adaptive immunity</article-title><source><italic toggle="yes">Blood</italic></source><year>2003</year><volume>101</volume><issue>9</issue><fpage>3520</fpage><lpage>3526</lpage><pub-id pub-id-type="doi">10.1182/blood-2002-10-3063</pub-id><pub-id pub-id-type="other">2-s2.0-0037903228</pub-id><pub-id pub-id-type="pmid">12511409</pub-id></element-citation></ref><ref id="B146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S.</given-names></name><name><surname>Crotta</surname><given-names>S.</given-names></name><name><surname>McCabe</surname><given-names>T. M.</given-names></name><name><surname>Wack</surname><given-names>A.</given-names></name></person-group><article-title>Pathogenic potential of interferon <italic>&#x003b1;&#x003b2;</italic> in acute influenza infection</article-title><source><italic toggle="yes">Nature Communications</italic></source><year>2014</year><volume>5</volume><issue>1</issue><pub-id pub-id-type="doi">10.1038/ncomms4864</pub-id><pub-id pub-id-type="other">2-s2.0-84901358668</pub-id></element-citation></ref><ref id="B147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boonnak</surname><given-names>K.</given-names></name><name><surname>Vogel</surname><given-names>L.</given-names></name><name><surname>Feldmann</surname><given-names>F.</given-names></name><name><surname>Feldmann</surname><given-names>H.</given-names></name><name><surname>Legge</surname><given-names>K. L.</given-names></name><name><surname>Subbarao</surname><given-names>K.</given-names></name></person-group><article-title>Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2014</year><volume>192</volume><issue>12</issue><fpage>5906</fpage><lpage>5912</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1302992</pub-id><pub-id pub-id-type="other">2-s2.0-84902179128</pub-id><?supplied-pmid 24829418?><pub-id pub-id-type="pmid">24829418</pub-id></element-citation></ref><ref id="B148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langlois</surname><given-names>R. A.</given-names></name><name><surname>Legge</surname><given-names>K. L.</given-names></name></person-group><article-title>Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells</article-title><source><italic toggle="yes">Journal of Immunology</italic></source><year>2010</year><volume>184</volume><issue>8</issue><fpage>4440</fpage><lpage>4446</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902984</pub-id><pub-id pub-id-type="other">2-s2.0-77952753345</pub-id><?supplied-pmid 20220091?><pub-id pub-id-type="pmid">20220091</pub-id></element-citation></ref><ref id="B149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waring</surname><given-names>P.</given-names></name><name><surname>Mullbacher</surname><given-names>A.</given-names></name></person-group><article-title>Cell death induced by the Fas/Fas ligand pathway and its role in pathology</article-title><source><italic toggle="yes">Immunology &#x00026; Cell Biology</italic></source><year>1999</year><volume>77</volume><issue>4</issue><fpage>312</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1711.1999.00837.x</pub-id><pub-id pub-id-type="other">2-s2.0-0032777102</pub-id><pub-id pub-id-type="pmid">10457197</pub-id></element-citation></ref><ref id="B150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soloff</surname><given-names>A. C.</given-names></name><name><surname>Weirback</surname><given-names>H. K.</given-names></name><name><surname>Ross</surname><given-names>T. M.</given-names></name><name><surname>Barratt-Boyes</surname><given-names>S. M.</given-names></name></person-group><article-title>Plasmacytoid dendritic cell depletion leads to an enhanced mononuclear phagocyte response in lungs of mice with lethal influenza virus infection</article-title><source><italic toggle="yes">Comparative Immunology, Microbiology and Infectious Diseases</italic></source><year>2012</year><volume>35</volume><issue>4</issue><fpage>309</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.cimid.2012.01.012</pub-id><pub-id pub-id-type="other">2-s2.0-84861760723</pub-id><?supplied-pmid 22421538?><pub-id pub-id-type="pmid">22421538</pub-id></element-citation></ref><ref id="B151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bramley</surname><given-names>A. M.</given-names></name><name><surname>Dasgupta</surname><given-names>S.</given-names></name><name><surname>Skarbinski</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Intensive care unit patients with 2009 pandemic influenza A (H1N1pdm09) virus infection - United States, 2009</article-title><source><italic toggle="yes">Influenza and Other Respiratory Viruses</italic></source><year>2012</year><volume>6</volume><issue>6</issue><fpage>e134</fpage><lpage>e142</lpage><pub-id pub-id-type="doi">10.1111/j.1750-2659.2012.00385.x</pub-id><pub-id pub-id-type="other">2-s2.0-84867727093</pub-id><pub-id pub-id-type="pmid">22672249</pub-id></element-citation></ref><ref id="B152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louie</surname><given-names>J. K.</given-names></name><name><surname>Acosta</surname><given-names>M.</given-names></name><name><surname>Winter</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California</article-title><source><italic toggle="yes">JAMA</italic></source><year>2009</year><volume>302</volume><issue>17</issue><fpage>1896</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1001/jama.2009.1583</pub-id><pub-id pub-id-type="other">2-s2.0-70449636557</pub-id><pub-id pub-id-type="pmid">19887665</pub-id></element-citation></ref><ref id="B153"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaillant</surname><given-names>L.</given-names></name><name><surname>la Ruche</surname><given-names>G.</given-names></name><name><surname>Tarantola</surname><given-names>A.</given-names></name><name><surname>Barboza</surname><given-names>P.</given-names></name><name><surname>epidemic intelligence team</surname></name></person-group><article-title>Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009</article-title><source><italic toggle="yes">Euro Surveillance</italic></source><year>2009</year><volume>14</volume><issue>33</issue><pub-id pub-id-type="doi">10.2807/ese.14.33.19309-en</pub-id><pub-id pub-id-type="other">2-s2.0-70350711888</pub-id></element-citation></ref><ref id="B154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terai</surname><given-names>M.</given-names></name><name><surname>Honda</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Early induction of interleukin-5 and peripheral eosinophilia in acute pneumonia in Japanese children infected by pandemic 2009 influenza A in the Tokyo area</article-title><source><italic toggle="yes">Microbiology and Immunology</italic></source><year>2011</year><volume>55</volume><issue>5</issue><fpage>341</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1111/j.1348-0421.2011.00320.x</pub-id><pub-id pub-id-type="other">2-s2.0-79955151417</pub-id><?supplied-pmid 21323726?><pub-id pub-id-type="pmid">21323726</pub-id></element-citation></ref><ref id="B155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorski</surname><given-names>S. A.</given-names></name><name><surname>Hahn</surname><given-names>Y. S.</given-names></name><name><surname>Braciale</surname><given-names>T. J.</given-names></name></person-group><article-title>Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2013</year><volume>9</volume><issue>9, article e1003615</issue><pub-id pub-id-type="doi">10.1371/journal.ppat.1003615</pub-id><pub-id pub-id-type="other">2-s2.0-84884683942</pub-id><?supplied-pmid 24068930?><pub-id pub-id-type="pmid">24068930</pub-id></element-citation></ref><ref id="B156"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiPiazza</surname><given-names>A.</given-names></name><name><surname>Nogales</surname><given-names>A.</given-names></name><name><surname>Poulton</surname><given-names>N.</given-names></name><name><surname>Wilson</surname><given-names>P. C.</given-names></name><name><surname>Mart&#x000ed;nez-Sobrido</surname><given-names>L.</given-names></name><name><surname>Sant</surname><given-names>A. J.</given-names></name></person-group><article-title>Pandemic 2009 H1N1 influenza Venus reporter virus reveals broad diversity of MHC class II-positive antigen-bearing cells following infection in vivo</article-title><source><italic toggle="yes">Scientific Reports</italic></source><year>2017</year><volume>7</volume><issue>1, article 10857</issue><pub-id pub-id-type="doi">10.1038/s41598-017-11313-x</pub-id><pub-id pub-id-type="other">2-s2.0-85028977826</pub-id></element-citation></ref><ref id="B157"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samarasinghe</surname><given-names>A. E.</given-names></name><name><surname>Woolard</surname><given-names>S. N.</given-names></name><name><surname>Boyd</surname><given-names>K. L.</given-names></name><name><surname>Hoselton</surname><given-names>S. A.</given-names></name><name><surname>Schuh</surname><given-names>J. M.</given-names></name><name><surname>McCullers</surname><given-names>J. A.</given-names></name></person-group><article-title>The immune profile associated with acute allergic asthma accelerates clearance of influenza virus</article-title><source><italic toggle="yes">Immunology and Cell Biology</italic></source><year>2014</year><volume>92</volume><issue>5</issue><fpage>449</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1038/icb.2013.113</pub-id><pub-id pub-id-type="other">2-s2.0-84901679097</pub-id><pub-id pub-id-type="pmid">24469764</pub-id></element-citation></ref><ref id="B158"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furze</surname><given-names>R. C.</given-names></name><name><surname>Hussell</surname><given-names>T.</given-names></name><name><surname>Selkirk</surname><given-names>M. E.</given-names></name></person-group><article-title>Amelioration of influenza-induced pathology in mice by coinfection with Trichinella spiralis</article-title><source><italic toggle="yes">Infection and Immunity</italic></source><year>2006</year><volume>74</volume><issue>3</issue><fpage>1924</fpage><lpage>1932</lpage><pub-id pub-id-type="doi">10.1128/IAI.74.3.1924-1932.2006</pub-id><pub-id pub-id-type="other">2-s2.0-33644774437</pub-id><pub-id pub-id-type="pmid">16495568</pub-id></element-citation></ref><ref id="B159"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J. J.</given-names></name><name><surname>Jacobsen</surname><given-names>E. A.</given-names></name><name><surname>McGarry</surname><given-names>M. P.</given-names></name><name><surname>Schleimer</surname><given-names>R. P.</given-names></name><name><surname>Lee</surname><given-names>N. A.</given-names></name></person-group><article-title>Eosinophils in health and disease: the LIAR hypothesis</article-title><source><italic toggle="yes">Clinical and Experimental Allergy</italic></source><year>2010</year><volume>40</volume><issue>4</issue><fpage>563</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2222.2010.03484.x</pub-id><pub-id pub-id-type="other">2-s2.0-77949349992</pub-id><pub-id pub-id-type="pmid">20447076</pub-id></element-citation></ref><ref id="B160"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samarasinghe</surname><given-names>A. E.</given-names></name><name><surname>Melo</surname><given-names>R. C. N.</given-names></name><name><surname>Duan</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Eosinophils promote antiviral immunity in mice infected with influenza A virus</article-title><source><italic toggle="yes">The Journal of Immunology</italic></source><year>2017</year><volume>198</volume><issue>8</issue><fpage>3214</fpage><lpage>3226</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600787</pub-id><pub-id pub-id-type="other">2-s2.0-85017399812</pub-id><?supplied-pmid 28283567?><pub-id pub-id-type="pmid">28283567</pub-id></element-citation></ref><ref id="B161"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>L. A.</given-names></name><name><surname>Szela</surname><given-names>C. T.</given-names></name><name><surname>Perez</surname><given-names>S. A. C.</given-names></name><etal/></person-group><article-title>Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially</article-title><source><italic toggle="yes">Journal of Leukocyte Biology</italic></source><year>2009</year><volume>85</volume><issue>1</issue><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1189/jlb.0108058</pub-id><pub-id pub-id-type="other">2-s2.0-58149271090</pub-id><pub-id pub-id-type="pmid">18840671</pub-id></element-citation></ref><ref id="B162"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ca&#x000f1;as</surname><given-names>J. A.</given-names></name><name><surname>Sastre</surname><given-names>B.</given-names></name><name><surname>Mazzeo</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Exosomes from eosinophils autoregulate and promote eosinophil functions</article-title><source><italic toggle="yes">Journal of Leukocyte Biology</italic></source><year>2017</year><volume>101</volume><issue>5</issue><fpage>1191</fpage><lpage>1199</lpage><pub-id pub-id-type="doi">10.1189/jlb.3AB0516-233RR</pub-id><pub-id pub-id-type="other">2-s2.0-85018428367</pub-id><pub-id pub-id-type="pmid">28096299</pub-id></element-citation></ref><ref id="B163"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeMessurier</surname><given-names>K. S.</given-names></name><name><surname>Samarasinghe</surname><given-names>A. E.</given-names></name></person-group><article-title>Eosinophils: nemeses of pulmonary pathogens?</article-title><source><italic toggle="yes">Current Allergy and Asthma Reports</italic></source><year>2019</year><volume>19</volume><issue>8</issue><fpage>p. 36</fpage><pub-id pub-id-type="doi">10.1007/s11882-019-0867-1</pub-id></element-citation></ref><ref id="B164"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Helden</surname><given-names>M. J. G.</given-names></name><name><surname>Zaiss</surname><given-names>D. M. W.</given-names></name><name><surname>Sijts</surname><given-names>A. J. A. M.</given-names></name></person-group><article-title>CCR2 defines a distinct population of NK cells and mediates their migration during influenza virus infection in mice</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2012</year><volume>7</volume><issue>12, article e52027</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0052027</pub-id><pub-id pub-id-type="other">2-s2.0-84871269568</pub-id><?supplied-pmid 23272202?><pub-id pub-id-type="pmid">23272202</pub-id></element-citation></ref><ref id="B165"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Thakar</surname><given-names>M. S.</given-names></name><name><surname>Ouyang</surname><given-names>W.</given-names></name><name><surname>Malarkannan</surname><given-names>S.</given-names></name></person-group><article-title>IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection</article-title><source><italic toggle="yes">Mucosal Immunology</italic></source><year>2013</year><volume>6</volume><issue>1</issue><fpage>69</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/mi.2012.49</pub-id><pub-id pub-id-type="other">2-s2.0-84867658823</pub-id><pub-id pub-id-type="pmid">22739232</pub-id></element-citation></ref><ref id="B166"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gazit</surname><given-names>R.</given-names></name><name><surname>Gruda</surname><given-names>R.</given-names></name><name><surname>Elboim</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2006</year><volume>7</volume><issue>5</issue><fpage>517</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1038/ni1322</pub-id><pub-id pub-id-type="other">2-s2.0-33645964977</pub-id><pub-id pub-id-type="pmid">16565719</pub-id></element-citation></ref><ref id="B167"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlin</surname><given-names>L. E.</given-names></name><name><surname>Hemann</surname><given-names>E. A.</given-names></name><name><surname>Zacharias</surname><given-names>Z. R.</given-names></name><name><surname>Heusel</surname><given-names>J. W.</given-names></name><name><surname>Legge</surname><given-names>K. L.</given-names></name></person-group><article-title>Natural killer cell recruitment to the lung during influenza A virus infection is dependent on CXCR3, CCR5, and virus exposure dose</article-title><source><italic toggle="yes">Frontiers in Immunology</italic></source><year>2018</year><volume>9</volume><fpage>p. 781</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00781</pub-id><pub-id pub-id-type="other">2-s2.0-85045751926</pub-id></element-citation></ref><ref id="B168"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forberg</surname><given-names>H.</given-names></name><name><surname>Hauge</surname><given-names>A. G.</given-names></name><name><surname>Valheim</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Early responses of natural killer cells in pigs experimentally infected with 2009 pandemic H1N1 influenza A virus</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2014</year><volume>9</volume><issue>6, article e100619</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0100619</pub-id><pub-id pub-id-type="other">2-s2.0-84903540513</pub-id></element-citation></ref><ref id="B169"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gr&#x000e9;goire</surname><given-names>C.</given-names></name><name><surname>Chasson</surname><given-names>L.</given-names></name><name><surname>Luci</surname><given-names>C.</given-names></name><etal/></person-group><article-title>The trafficking of natural killer cells</article-title><source><italic toggle="yes">Immunological Reviews</italic></source><year>2007</year><volume>220</volume><issue>1</issue><fpage>169</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2007.00563.x</pub-id><pub-id pub-id-type="other">2-s2.0-35748950110</pub-id><pub-id pub-id-type="pmid">17979846</pub-id></element-citation></ref><ref id="B170"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivier</surname><given-names>E.</given-names></name><name><surname>Tomasello</surname><given-names>E.</given-names></name><name><surname>Baratin</surname><given-names>M.</given-names></name><name><surname>Walzer</surname><given-names>T.</given-names></name><name><surname>Ugolini</surname><given-names>S.</given-names></name></person-group><article-title>Functions of natural killer cells</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2008</year><volume>9</volume><issue>5</issue><fpage>503</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1038/ni1582</pub-id><pub-id pub-id-type="other">2-s2.0-42449151214</pub-id><pub-id pub-id-type="pmid">18425107</pub-id></element-citation></ref><ref id="B171"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>H.</given-names></name><name><surname>Tu</surname><given-names>W.</given-names></name><name><surname>Qin</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Influenza virus directly infects human natural killer cells and induces cell apoptosis</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2009</year><volume>83</volume><issue>18</issue><fpage>9215</fpage><lpage>9222</lpage><pub-id pub-id-type="doi">10.1128/JVI.00805-09</pub-id><pub-id pub-id-type="other">2-s2.0-69449083335</pub-id><?supplied-pmid 19587043?><pub-id pub-id-type="pmid">19587043</pub-id></element-citation></ref><ref id="B172"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnon</surname><given-names>T. I.</given-names></name><name><surname>Achdout</surname><given-names>H.</given-names></name><name><surname>Lieberman</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46</article-title><source><italic toggle="yes">Blood</italic></source><year>2004</year><volume>103</volume><issue>2</issue><fpage>664</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1182/blood-2003-05-1716</pub-id><pub-id pub-id-type="other">2-s2.0-9144250952</pub-id><pub-id pub-id-type="pmid">14504081</pub-id></element-citation></ref><ref id="B173"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandelboim</surname><given-names>O.</given-names></name><name><surname>Lieberman</surname><given-names>N.</given-names></name><name><surname>Lev</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells</article-title><source><italic toggle="yes">Nature</italic></source><year>2001</year><volume>409</volume><issue>6823</issue><fpage>1055</fpage><lpage>1060</lpage><pub-id pub-id-type="doi">10.1038/35059110</pub-id><pub-id pub-id-type="other">2-s2.0-0035931861</pub-id><pub-id pub-id-type="pmid">11234016</pub-id></element-citation></ref><ref id="B174"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>N.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2010</year><volume>84</volume><issue>15</issue><fpage>7822</fpage><lpage>7831</lpage><pub-id pub-id-type="doi">10.1128/JVI.00069-10</pub-id><pub-id pub-id-type="other">2-s2.0-77954464010</pub-id><?supplied-pmid 20484512?><pub-id pub-id-type="pmid">20484512</pub-id></element-citation></ref><ref id="B175"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Valdez</surname><given-names>P. A.</given-names></name><name><surname>Danilenko</surname><given-names>D. M.</given-names></name><etal/></person-group><article-title>Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens</article-title><source><italic toggle="yes">Nature Medicine</italic></source><year>2008</year><volume>14</volume><issue>3</issue><fpage>282</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1038/nm1720</pub-id><pub-id pub-id-type="other">2-s2.0-40049083827</pub-id></element-citation></ref><ref id="B176"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kok</surname><given-names>W. L.</given-names></name><name><surname>Denney</surname><given-names>L.</given-names></name><name><surname>Benam</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Pivotal advance: invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection</article-title><source><italic toggle="yes">Journal of Leukocyte Biology</italic></source><year>2012</year><volume>91</volume><issue>3</issue><fpage>357</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1189/jlb.0411184</pub-id><pub-id pub-id-type="other">2-s2.0-84857880036</pub-id><pub-id pub-id-type="pmid">22003207</pub-id></element-citation></ref><ref id="B177"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Santo</surname><given-names>C.</given-names></name><name><surname>Salio</surname><given-names>M.</given-names></name><name><surname>Masri</surname><given-names>S. H.</given-names></name><etal/></person-group><article-title>Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans</article-title><source><italic toggle="yes">The Journal of Clinical Investigation</italic></source><year>2008</year><volume>118</volume><issue>12</issue><fpage>4036</fpage><lpage>4048</lpage><pub-id pub-id-type="doi">10.1172/JCI36264</pub-id><pub-id pub-id-type="other">2-s2.0-57449088879</pub-id><?supplied-pmid 19033672?><pub-id pub-id-type="pmid">19033672</pub-id></element-citation></ref><ref id="B178"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paget</surname><given-names>C.</given-names></name><name><surname>Ivanov</surname><given-names>S.</given-names></name><name><surname>Fontaine</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages</article-title><source><italic toggle="yes">Journal of Biological Chemistry</italic></source><year>2012</year><volume>287</volume><issue>12</issue><fpage>8816</fpage><lpage>8829</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.304758</pub-id><pub-id pub-id-type="other">2-s2.0-84858587977</pub-id><pub-id pub-id-type="pmid">22294696</pub-id></element-citation></ref><ref id="B179"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivier</surname><given-names>E.</given-names></name><name><surname>Artis</surname><given-names>D.</given-names></name><name><surname>Colonna</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Innate lymphoid cells: 10 years on</article-title><source><italic toggle="yes">Cell</italic></source><year>2018</year><volume>174</volume><issue>5</issue><fpage>1054</fpage><lpage>1066</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.07.017</pub-id><pub-id pub-id-type="other">2-s2.0-85050861774</pub-id><pub-id pub-id-type="pmid">30142344</pub-id></element-citation></ref><ref id="B180"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artis</surname><given-names>D.</given-names></name><name><surname>Spits</surname><given-names>H.</given-names></name></person-group><article-title>The biology of innate lymphoid cells</article-title><source><italic toggle="yes">Nature</italic></source><year>2015</year><volume>517</volume><issue>7534</issue><fpage>293</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1038/nature14189</pub-id><pub-id pub-id-type="other">2-s2.0-84922607138</pub-id><pub-id pub-id-type="pmid">25592534</pub-id></element-citation></ref><ref id="B181"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberl</surname><given-names>G.</given-names></name><name><surname>Colonna</surname><given-names>M.</given-names></name><name><surname>di Santo</surname><given-names>J. P.</given-names></name><name><surname>McKenzie</surname><given-names>A. N. J.</given-names></name></person-group><article-title>Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology</article-title><source><italic toggle="yes">Science</italic></source><year>2015</year><volume>348</volume><issue>6237, article aaa6566</issue><pub-id pub-id-type="doi">10.1126/science.aaa6566</pub-id><pub-id pub-id-type="other">2-s2.0-84929996266</pub-id><?supplied-pmid 25999512?><pub-id pub-id-type="pmid">25999512</pub-id></element-citation></ref><ref id="B182"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spits</surname><given-names>H.</given-names></name><name><surname>Artis</surname><given-names>D.</given-names></name><name><surname>Colonna</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Innate lymphoid cells &#x02014; a proposal for uniform nomenclature</article-title><source><italic toggle="yes">Nature Reviews Immunology</italic></source><year>2013</year><volume>13</volume><issue>2</issue><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1038/nri3365</pub-id><pub-id pub-id-type="other">2-s2.0-84872977452</pub-id></element-citation></ref><ref id="B183"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B. W. S.</given-names></name><name><surname>de Bruijn</surname><given-names>M. J. W.</given-names></name><name><surname>Lukkes</surname><given-names>M.</given-names></name><etal/></person-group><article-title>T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice</article-title><source><italic toggle="yes">European Journal of Immunology</italic></source><year>2019</year><volume>49</volume><issue>1</issue><fpage>144</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1002/eji.201747421</pub-id><pub-id pub-id-type="other">2-s2.0-85059499120</pub-id><pub-id pub-id-type="pmid">29762870</pub-id></element-citation></ref><ref id="B184"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>K. M.</given-names></name><name><surname>Ramanan</surname><given-names>K.</given-names></name><name><surname>Clay</surname><given-names>M. E.</given-names></name><name><surname>McHugh</surname><given-names>K. J.</given-names></name><name><surname>Rich</surname><given-names>H. E.</given-names></name><name><surname>Alcorn</surname><given-names>J. F.</given-names></name></person-group><article-title>Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection</article-title><source><italic toggle="yes">Mucosal Immunology</italic></source><year>2018</year><volume>11</volume><issue>1</issue><fpage>199</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1038/mi.2017.32</pub-id><pub-id pub-id-type="other">2-s2.0-85038866367</pub-id><?supplied-pmid 28401938?><pub-id pub-id-type="pmid">28401938</pub-id></element-citation></ref><ref id="B185"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirchandani</surname><given-names>A. S.</given-names></name><name><surname>Salmond</surname><given-names>R. J.</given-names></name><name><surname>Liew</surname><given-names>F. Y.</given-names></name></person-group><article-title>Interleukin-33 and the function of innate lymphoid cells</article-title><source><italic toggle="yes">Trends in Immunology</italic></source><year>2012</year><volume>33</volume><issue>8</issue><fpage>389</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1016/j.it.2012.04.005</pub-id><pub-id pub-id-type="other">2-s2.0-84864145383</pub-id><pub-id pub-id-type="pmid">22609147</pub-id></element-citation></ref><ref id="B186"><label>186</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Goffic</surname><given-names>R.</given-names></name><name><surname>Arshad</surname><given-names>M. I.</given-names></name><name><surname>Rauch</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Infection with influenza virus induces IL-33 in murine lungs</article-title><source><italic toggle="yes">American Journal of Respiratory Cell and Molecular Biology</italic></source><year>2011</year><volume>45</volume><issue>6</issue><fpage>1125</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2010-0516OC</pub-id><pub-id pub-id-type="other">2-s2.0-82755174177</pub-id><?supplied-pmid 21642589?><pub-id pub-id-type="pmid">21642589</pub-id></element-citation></ref><ref id="B187"><label>187</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y. J.</given-names></name><name><surname>Kim</surname><given-names>H. Y.</given-names></name><name><surname>Albacker</surname><given-names>L. A.</given-names></name><etal/></person-group><article-title>Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2011</year><volume>12</volume><issue>7</issue><fpage>631</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1038/ni.2045</pub-id><pub-id pub-id-type="other">2-s2.0-79959380307</pub-id><pub-id pub-id-type="pmid">21623379</pub-id></element-citation></ref><ref id="B188"><label>188</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monticelli</surname><given-names>L. A.</given-names></name><name><surname>Sonnenberg</surname><given-names>G. F.</given-names></name><name><surname>Abt</surname><given-names>M. C.</given-names></name><etal/></person-group><article-title>Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus</article-title><source><italic toggle="yes">Nature Immunology</italic></source><year>2011</year><volume>12</volume><issue>11</issue><fpage>1045</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1038/ni.2131</pub-id><pub-id pub-id-type="other">2-s2.0-85027948313</pub-id><pub-id pub-id-type="pmid">21946417</pub-id></element-citation></ref><ref id="B189"><label>189</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Califano</surname><given-names>D.</given-names></name><name><surname>Furuya</surname><given-names>Y.</given-names></name><name><surname>Roberts</surname><given-names>S.</given-names></name><name><surname>Avram</surname><given-names>D.</given-names></name><name><surname>McKenzie</surname><given-names>A. N. J.</given-names></name><name><surname>Metzger</surname><given-names>D. W.</given-names></name></person-group><article-title>IFN-<italic>&#x003b3;</italic> increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells</article-title><source><italic toggle="yes">Mucosal Immunology</italic></source><year>2018</year><volume>11</volume><issue>1</issue><fpage>209</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1038/mi.2017.41</pub-id><pub-id pub-id-type="other">2-s2.0-85038848149</pub-id><?supplied-pmid 28513592?><pub-id pub-id-type="pmid">28513592</pub-id></element-citation></ref><ref id="B190"><label>190</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>Y. H.</given-names></name><name><surname>Meyer</surname><given-names>C.</given-names></name><name><surname>Bonneville</surname><given-names>M.</given-names></name></person-group><article-title>
<italic>&#x003b3;&#x003b4;</italic> T cells: first line of defense and beyond</article-title><source><italic toggle="yes">Annual Review of Immunology</italic></source><year>2014</year><volume>32</volume><issue>1</issue><fpage>121</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120216</pub-id><pub-id pub-id-type="other">2-s2.0-84896966923</pub-id></element-citation></ref><ref id="B191"><label>191</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>W.</given-names></name><name><surname>Zheng</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a <italic>&#x003b3;&#x003b4;</italic> T cell population in humanized mice</article-title><source><italic toggle="yes">Journal of Experimental Medicine</italic></source><year>2011</year><volume>208</volume><issue>7</issue><fpage>1511</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1084/jem.20110226</pub-id><pub-id pub-id-type="other">2-s2.0-79960360772</pub-id><?supplied-pmid 21708931?><pub-id pub-id-type="pmid">21708931</pub-id></element-citation></ref><ref id="B192"><label>192</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Type 1 responses of human V<italic>&#x003b3;</italic>9V<italic>&#x003b4;</italic>2 T cells to influenza A viruses</article-title><source><italic toggle="yes">Journal of Virology</italic></source><year>2011</year><volume>85</volume><issue>19</issue><fpage>10109</fpage><lpage>10116</lpage><pub-id pub-id-type="doi">10.1128/JVI.05341-11</pub-id><pub-id pub-id-type="other">2-s2.0-80053973676</pub-id><?supplied-pmid 21752902?><pub-id pub-id-type="pmid">21752902</pub-id></element-citation></ref><ref id="B193"><label>193</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glatzel</surname><given-names>A.</given-names></name><name><surname>Wesch</surname><given-names>D.</given-names></name><name><surname>Schiemann</surname><given-names>F.</given-names></name><name><surname>Brandt</surname><given-names>E.</given-names></name><name><surname>Janssen</surname><given-names>O.</given-names></name><name><surname>Kabelitz</surname><given-names>D.</given-names></name></person-group><article-title>Patterns of chemokine receptor expression on peripheral blood <italic>&#x003b3;&#x003b4;</italic> T lymphocytes: strong expression of CCR5 is a selective feature of V<italic>&#x003b4;</italic>2/V<italic>&#x003b3;</italic>9 <italic>&#x003b3;&#x003b4;</italic> T cells</article-title><source><italic toggle="yes">The Journal of Immunology</italic></source><year>2002</year><volume>168</volume><issue>10</issue><fpage>4920</fpage><lpage>4929</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.168.10.4920</pub-id><?supplied-pmid 11994442?><pub-id pub-id-type="pmid">11994442</pub-id></element-citation></ref><ref id="B194"><label>194</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Xiang</surname><given-names>Z.</given-names></name><name><surname>Feng</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Human V<italic>&#x003b3;</italic>9V<italic>&#x003b4;</italic>2-T cells efficiently kill influenza virus-infected lung alveolar epithelial cells</article-title><source><italic toggle="yes">Cellular &#x00026; Molecular Immunology</italic></source><year>2013</year><volume>10</volume><issue>2</issue><fpage>159</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1038/cmi.2012.70</pub-id><pub-id pub-id-type="other">2-s2.0-84874641643</pub-id><?supplied-pmid 23353835?><pub-id pub-id-type="pmid">23353835</pub-id></element-citation></ref><ref id="B195"><label>195</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>G.</given-names></name><name><surname>Mao</surname><given-names>H.</given-names></name><name><surname>Zheng</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Phosphoantigen-expanded human <italic>&#x003b3;&#x003b4;</italic> T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses</article-title><source><italic toggle="yes">The Journal of Infectious Diseases</italic></source><year>2009</year><volume>200</volume><issue>6</issue><fpage>858</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1086/605413</pub-id><pub-id pub-id-type="other">2-s2.0-70349417911</pub-id><pub-id pub-id-type="pmid">19656068</pub-id></element-citation></ref><ref id="B196"><label>196</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jameson</surname><given-names>J. M.</given-names></name><name><surname>Cruz</surname><given-names>J.</given-names></name><name><surname>Costanzo</surname><given-names>A.</given-names></name><name><surname>Terajima</surname><given-names>M.</given-names></name><name><surname>Ennis</surname><given-names>F. A.</given-names></name></person-group><article-title>A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human <italic>&#x003b3;&#x003b4;</italic> T lymphocytes</article-title><source><italic toggle="yes">Cellular Immunology</italic></source><year>2010</year><volume>264</volume><issue>1</issue><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2010.04.013</pub-id><pub-id pub-id-type="other">2-s2.0-77954142065</pub-id><?supplied-pmid 20483407?><pub-id pub-id-type="pmid">20483407</pub-id></element-citation></ref><ref id="B197"><label>197</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>P.</given-names></name><name><surname>Ju</surname><given-names>X.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b3;&#x003b4;</italic> T cells provide protective function in highly pathogenic avian H5N1 influenza A virus infection</article-title><source><italic toggle="yes">Frontiers in Immunology</italic></source><year>2018</year><volume>9</volume><fpage>p. 2812</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.02812</pub-id><pub-id pub-id-type="other">2-s2.0-85058903665</pub-id></element-citation></ref><ref id="B198"><label>198</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Ma</surname><given-names>C.</given-names></name><etal/></person-group><article-title>The interaction of influenza H5N1 viral hemagglutinin with sialic acid receptors leads to the activation of human <italic>&#x003b3;&#x003b4;</italic> T cells</article-title><source><italic toggle="yes">Cellular &#x00026; Molecular Immunology</italic></source><year>2013</year><volume>10</volume><issue>6</issue><fpage>463</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1038/cmi.2013.26</pub-id><pub-id pub-id-type="other">2-s2.0-84888383742</pub-id><?supplied-pmid 23912782?><pub-id pub-id-type="pmid">23912782</pub-id></element-citation></ref><ref id="B199"><label>199</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X. J.</given-names></name><name><surname>Dash</surname><given-names>P.</given-names></name><name><surname>Crawford</surname><given-names>J. C.</given-names></name><etal/></person-group><article-title>Lung <italic>&#x003b3;&#x003b4;</italic> T cells mediate protective responses during neonatal influenza infection that are associated with type 2 immunity</article-title><source><italic toggle="yes">Immunity</italic></source><year>2018</year><volume>49</volume><issue>3</issue><fpage>531</fpage><lpage>544.e6</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.07.011</pub-id><pub-id pub-id-type="other">2-s2.0-85055586852</pub-id><?supplied-pmid 30170813?><pub-id pub-id-type="pmid">30170813</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Schematic representation of neutrophil-mediated host defense mechanisms during influenza virus infection. Influenza A virus- (IAV)-infected airway epithelium releases neutrophil chemoattractants: CXCL1 and CXCL2. Neutrophils traffic into infected lungs by digesting endothelial basement membrane collagen. During trafficking, they release CXCL12-loaded vesicles/membranes which provide signals for CD8<sup>+</sup> T cell migration and effector function. Once in the lungs, neutrophils secrete antimicrobial peptides and cytokines, including IFN<italic>&#x003b3;</italic>, to inhibit IAV replication. TNF<italic>&#x003b1;</italic> produced by infected airway epithelium triggers the formation of neutrophil extracellular traps (NETs) which neutralize IAV particles. Enhanced NETosis damages airway epithelium and endothelium leading to severe pneumonia.</p></caption><graphic xlink:href="JIR2019-8028725.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Schematic representation of monocyte-, macrophage-, and dendritic cell- (DC-) controlled immunoprotection and immunopathology during influenza virus infection. Influenza A virus- (IAV-) infected airway epithelium produces monocyte chemoattractants: CCL2, CCL3, and CCL5. Monocytes interact with endothelium through <italic>&#x003b2;</italic>1 integrin, VCAM-1, and <italic>&#x003b2;</italic>2 integrin, ICAM-1, binding, and subsequent entry into the lung tissue is assisted by JAM. These activated monocytes secrete inflammatory cytokines that inhibit IAV replication. Monocytes exert anti-IAV activity by differentiating into phagocytic cells like macrophages and DCs. IAV infection downregulates CD200-CD200R activating macrophages. These activated macrophages release an array of inflammatory cytokines that limit IAV replication. Both conventional and plasmacytoid DCs (cDCs and pDCs) exert anti-IAV activity in lungs. IAV-activated cDCs migrate to lymph node and present antigen to CD8<sup>+</sup> T cells. Chemokines, CCL12 and CCL17, secreted by infected airway epithelium provide signals for the activated cytotoxic T cells trafficking into the lungs where they lyse IAV-infected cells. The other DC subset, pDC migrate to lymph node and stimulate B cell differentiation into antibody secreting plasma cells. These antibodies neutralize IAV particles conferring humoral protection.</p></caption><graphic xlink:href="JIR2019-8028725.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Immunoprotection and immunopathology mediated by eosinophils and natural killer (NK) cells during influenza. CCL5 and IL-5 released by IAV-infected airway epithelium mediate eosinophil trafficking into the lungs. Eosinophils undergo piecemeal degranulation and secrete inflammatory cytokines that exert anti-IAV activity. Additionally, IAV-infected eosinophils migrate to draining lymph nodes to present viral antigen to CD8<sup>+</sup> T cells. Once activated, cytotoxic T cells traffic to the lungs to lyse IAV-infected cells. NK cell recruitment is driven by CCL2, CCL5, CXCL9, CXCL10, and CXCL11 secreted by IAV-infected airway epithelium. Engagement of IAV with NK cell receptor NKp46 activates NK cell effector functions. Perforins, granzyme B, and IFN<italic>&#x003b3;</italic> released by NK cell destroy IAV-infected cells while IL-22 aids in the regeneration of damaged epithelium.</p></caption><graphic xlink:href="JIR2019-8028725.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Innate lymphoid cells (ILCs) and <italic>&#x003b3;&#x003b4;</italic> T cells are important during early stages of influenza virus infection. Schematic representation of immunoprotection and immunopathology mediated by ILCs in the IAV-infected lungs. <italic>&#x003b3;&#x003b4;</italic> T cell migration into the infected lungs is driven along the CCR5-CCL5 axis. <italic>&#x003b3;&#x003b4;</italic> T cells destroy infected cells through the secretion of IFN<italic>&#x003b3;</italic> and perforin-granzyme B pathway and secrete IL-17A to trigger airway epithelium release of IL-33, a chemoattractant for ILC2. In addition, IL-33 secreted by IAV-infected epithelium enhances the trafficking of ILC2 into the lungs. Activated ILC2s release amphiregulin (Areg) which helps to repair tissue damage and IL-5 which induces eosinophil trafficking.</p></caption><graphic xlink:href="JIR2019-8028725.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Yin and Yang of innate immune cell functions during influenza virus infection. At steady state, innate immune cells corporate to maintain pulmonary homeostasis while clearing IAV effectively with minimal tissue damage. When infected with a highly pathogenic virus or when immediate immune responses are unable to clear the infection, the immune system goes on overdrive causing excessive proinflammatory cytokine production and uncontrolled inflammation which can be pathogenic and detrimental to the host.</p></caption><graphic xlink:href="JIR2019-8028725.005"/></fig></floats-group></article>